{
  "specialty": "cardiology",
  "abstracts": [
    "1. kardiologiia. 2025 jul 76565473. doi 10.18087cardio.2025.6.n2921. mental disorders in patients with cardiovascular diseases. consensus statement by the task force of the russian society of cardiology and the russian society of psychiatrists. article in russian belialov fi1 veltishchev dy2 volel ba3 garganeeva np4 kopylov fy3 lareva nv5 medvedev ve6 mosolov sn1 petrova mm7 petrunko ov1 poponina tm4 repin an8 sobennikov vs9 sumin an10. author information 1russian medical academy of continuing professional education. 2pirogov russian national research medical university. 3sechenov first moscow state medical university. 4siberian state medical university. 5chita state medical academy. 6patrice lumumba peoples friendship university of russia. 7voynoyasenetsky krasnoyarsk state medical university. 8tomsk national research medical center of the russian academy of sciences. 9irkutsk state medical university. 10research institute for complex issues of cardiovascular diseases. experts of the working groups of the russian society of cardiology and the russian society of psychiatrists the baikal and siberian psychosomatic associations have developed guidelines on the diagnosis and treatment of common mental disorders in patients with cardiovascular diseases. the provisions of the document are based on the results of the most reliable scientific research and recommendations of authoritative medical societies and are intended to inform physicians about good clinical practice. this document reflects the position of professional organizations on a relevant interdisciplinary problem.the agreed document is intended for cardiologists general practitioners psychiatrists and other medical specialists who provide care to patients with cardiovascular diseases and comorbid mental disorders. doi 10.18087cardio.2025.6.n2921 pmid 40627427 indexed for medline",
    "2. j am heart assoc. 2025 jul 151414e039868. doi 10.1161jaha.124.039868. epub 2025 jul 3. application of the american heart associationamerican college of cardiologyheart failure society of america heart failure staging guidelines in adults with chronic kidney disease. zemke am1 zelnick lr1 ix jh23 go as4 siew ed56 bansal n1. author information 1kidney research institute division of nephrology university of washington seattle wa usa. 2division of nephrologyhypertension department of medicine university of california san diego san diego ca usa. 3veterans affairs san diego healthcare system san diego ca usa. 4division of research kaiser permanente northern california pleasanton ca usa. 5division of nephrology and hypertension department of medicine vanderbilt university medical center nashville tn usa. 6tennessee valley health services nashville va nashville tn usa. background in 2022 the american heart associationamerican college of cardiologyheart failure society of america guidelines for management of heart failure proposed an updated staging system with cardiac biomarkers to diagnose heart failure hf and its severity. the applicability of this staging system in chronic kidney disease is not well established. methods this is a prospective cohort study of 2415 participants from cric chronic renal insufficiency cohort. individuals were classified into hf stages using 2013 and 2022 american heart associationamerican college of cardiologyheart failure society of america hf guidelines using research echocardiograms cardiac biomarkers troponin t 10 ngl women 15 ngl men probtype natriuretic peptide 125 pgml laboratory measures and history. adjudicated outcomes of hf hospitalizations and allcause mortality are reported. results in individuals with chronic kidney disease participants with lower estimated glomerular filtration rates were more likely to be reclassified to a more advanced hf stage using the current proposed thresholds of hstnt highsensitivity troponin t and ntprobnp nterminal probtype natriuretic peptide. the 2022 guidelines reclassified 55 of 2013 guideline stage a participants to stage b. hf hospitalization incidence rates differed when individuals were categorized into stage b hf based on elevated hstnt or ntprobnp 1.7 per 100 personyears compared with echocardiographic abnormalities 2.9 per 100 personyears whereas death rates were similar between these groups. conclusions among individuals with ckd the addition of elevated hstnt or ntprobnp to hf staging reclassified nearly 20 of total participants into a higher hf stage. these individuals had similar mortality rates to those previously in higher stages but they had lower hf hospitalization rates. those with more advanced chronic kidney disease were more likely to be reclassified. doi 10.1161jaha.124.039868 pmid 40611482 indexed for medline",
    "3. oncology williston park. 2025 jun 16null5188197. doi 10.468832025.25921044. cardiooncology considerations for breast cancer risk stratification monitoring and treatment. wallins j saravia s bolaji o shaikh z yu a. longterm outcomes of patients with breast cancer have steadily improved due to advances in early detection and cancer therapeutics. cardiovascular disease cvd is a leading cause of noncancerrelated mortality in this population and this has been attributed to the cardiovascular toxicity of common breast cancer treatments including chemotherapy and radiation as well as shared risk factors between cancer and cvd. identifying patients at risk of developing treatmentrelated cardiotoxicities is crucial to inform clinical decisions regarding surveillance prevention and management. in this review we provide a broad overview of the treatmentrelated cardiotoxicities associated with common breast cancer treatment. we present data on riskstratification tools for oncologists including when to refer to a cardiologist as well as recommendations for cardiovascular testing tailored to individual treatment regimens. lastly we review recent trial data on preventive and therapeutic approaches to treatmentrelated cardiotoxicities and future directions that may lead to improved cardiovascular outcomes in this population. doi 10.468832025.25921044 pmid 40600749 indexed for medline",
    "4. j nucl cardiol. 2024 oct40102041. doi 10.1016j.nuclcard.2024.102041. epub 2024 sep 12. american society of nuclear cardiology quality metrics for cardiac amyloid radionuclide imaging. hage fg1 bourque jm2 pandey s3 shah nr4 soman p5 abbott bg4 abidov a6 aggarwal nr7 aljaroudi w8 bhambhvani pg9 bokhari s10 dorbala s11 doukky r12 duran jm13 einstein aj14 gallagher d15 hendel rc16 jaber w17 kattan cg18 malhotra s12 masri a19 miller ej18 murthy vl20 sperry bw21. author information 1section of cardiology birmingham va medical center birmingham al usa division of cardiovascular disease department of medicine university of alabama at birmingham birmingham al usa. electronic address fadihageuab.edu. 2department of medicine cardiology department of radiology and medical imaging university of virginia health system charlottesville va usa. 3nuclear cardiology boston medical center boston ma usa. 4division of cardiology department of medicine brown university alpert medical school providence ri usa. 5division of cardiology cardiac amyloidosis center university of pittsburgh pittsburgh pa usa. 6wayne state university school of medicine and section of cardiology john d. dingell va medical center detroit mi usa. 7department of cardiovascular medicine mayo clinic health system rochester mn usa. 8division of cardiovascular medicine wellstar medical college of georgia augusta ga usa. 9division of molecular imaging and therapeutics department of radiology the university of alabama at birmingham birmingham al usa. 10division of cardiovascular medicine and hypertension rutgersrobert wood johnson medical school new brunswick nj usa. 11cardiovascular medicine radiology brigham and womens hospital boston ma usa. 12division of cardiology cook county health and hospitals system chicago il usa. 13division of cardiology vanderbilt health nashville tn usa. 14seymour paul and gloria milstein division of cardiology department of medicine and department of radiology columbia university irving medical center and newyorkpresbyterian hospital new york ny usa. 15patient author monroe ct usa. 16department of medicine division of cardiology tulane university school of medicine new orleans la usa. 17cardiovascular medicine cleveland clinic cleveland oh usa. 18division of cardiology yale school of medicine new haven ct usa. 19division of cardiovascular medicine school of medicine ohsu center for hypertrophic cardiomyopathy and amyloidosis portland or usa. 20frankel cardiovascular center radiology university michigan medicine ann arbor mi usa. 21mid america heart institute saint lukes health system kansas city mo usa. this document from the american society of nuclear cardiology develops metrics for the assessment of quality for laboratories that perform cardiac amyloid radionuclide imaging. these metrics are based on clinical guidelines appropriate use criteria information and position statements and expert opinion. the document introduces 15 quality metrics that address current gaps in care organized around 4 axes a appropriate indications b patient experience and workflow c instrumentation and protocols and d interpretation and reporting. with the increasing use of imaging for cardiac amyloid it is imperative that our laboratories maintain a high level of quality to preserve the value that imaging provides to patients. laboratories should perform imaging in appropriately selected patients avoiding lowvalue imaging. proper education should be provided to patients prior to performing testing timely access to testing must be available and periodic assessment of patient experience and satisfaction should be the norm. strict adherence to established protocols with periodic assessment of laboratory quality control is essential. laboratory studies to rule out plasma cell dyscrasia should be performed in all patients suspected of having cardiac amyloidosis. crucially interpretation should be based on spect rather than planar imaging in all patients. the study report should include sufficient technical details to allow for proper interpretation of study findings and its conclusion should be clear and unambiguous to guide clinical management. laboratories can use data derived from these metrics to identify areas of deficiency and introduce quality improvement initiatives which will ultimately improve patient outcomes. copyright 2025. published by elsevier inc. doi 10.1016j.nuclcard.2024.102041 pmid 40590833 indexed for medline",
    "5. j cardiovasc med hagerstown. 2025 jul 1267325338. doi 10.2459jcm.0000000000001740. epub 2025 may 30. comprehensive insights into peripheral artery disease an overview from the working groups of pathogenesis of atherosclerosis and thrombosis of the italian society of cardiology. muscoli s1 cimmino g23 canonico me4 cesaro a25 de rosa g6 de rosa s7 coronelli mm8 natale f29 perrone ma10 sticchi a11 sorrentino s7 sucato v12 renda g13 paolillo s6 indolfi c14 calabr p25 perrone filardi p6 cirillo p6. author information 1division of cardiology policlinico tor vergata rome. 2department of translational medical sciences section of cardiology university of campania luigi vanvitelli. 3uosd cardiologia azienda ospedaliera universitaria luigi vanvitelli naples italy. 4cpc clinical research aurora colorado usa university of colorado school of medicine aurora colorado usa. 5division of cardiology a.o.r.n. santanna e san sebastiano caserta. 6department of advanced biomedical sciences university of naples federico ii naples. 7department of medical and surgical sciences university magna grcia of catanzaro. 8department of internal medicine and medical therapy university of pavia. 9department of life science health and health professions link campus university. 10division of cardiology and cardiolab department of clinical sciences and translational medicine university of rome tor vergata rome. 11university of pisa 56126 pisa. 12department of health promotion mother and child care internal medicine and medical specialties promise g. dalessandro university of palermo palermo. 13department of neuroscience imaging and clinical sciences g. dannunzio university of chietipescara chieti 66100 italy heart department ss. annunziata hospital university cardiology division chieti. 14department of pharmacy health and nutritional sciences university of calabria 87036 rende italy. peripheral artery disease pad is a global health burden due to its high prevalence morbidity and mortality. it affects more than 200 million people worldwide. pad is a manifestation of systemic atherosclerosis that is often associated with coronary and cerebrovascular disease underscoring its crucial role as an indicator of advanced vascular pathology. despite its strong association with cardiovascular morbidity pad remains underdiagnosed and undertreated compared with coronary artery disease cad highlighting a significant gap in care. patients with pad are at increased risk of myocardial infarction mi stroke and limb amputation so a multidisciplinary approach is required to reduce adverse outcomes. identifying atrisk patients through early screening and implementing evidencebased therapeutic strategies is crucial in treating pad. modern lipidlowering agents dual antithrombotic therapies and aggressive risk factor control are essential treatment components. recent advances including pcsk9 inhibitors and novel antiplatelet agents have shown promise for improving cardiovascular and limbrelated outcomes although further validation is needed. given the systemic nature of atherosclerosis managing pad should be a cornerstone of cardiovascular care requiring individualised treatment plans. increasing awareness and understanding of pad is critical to bridging gaps in diagnosis and treatment to improve the overall prognosis and quality of life of patients with this debilitating disease. this work aims to enhance practical approaches to pad by providing comprehensive insights into its management and offering a foundation for exploring innovative future treatment options. copyright 2025 italian federation of cardiology i.f.c. all rights reserved. doi 10.2459jcm.0000000000001740 pmid 40590724 indexed for medline",
    "6. int nurs rev. 2025 sep723e70054. doi 10.1111inr.70054. exploring the role of advanced practice nurses in cardiology a scoping review. sguanci m1 mancin s2 car v3 simonelli n45 cangelosi g6 morales palomares s7 ferrara g8 lo cascio a9. author information 1polyclinic san martino hospital genoa italy. 2irccs humanitas research hospital rozzano milan italy. 3department of cardiology circolo e fondazione macchi hospital asst sette laghi varese italy. 4department of translational medicine university of piemonte orientale novara italy. 5ss antonio e biagio e c.arrigo university hospital alessandria italy. 6units of diabetology asur marche fermo italy. 7department of pharmacy health and nutritional sciences dfssn university of calabria rende italy. 8nephrology and dialysis unit ramazzini hospital carpi italy. 9department of biomedicine and prevention tor vergata university rome italy. aim to analyze the role of advanced practice nursing apn in the cardiology context in outpatient and inpatient settings detailing their roles competencies and responsibilities. it also provides an overview of the main degrees and postgraduate training programs for specialization in cardiology management in major western countries. background the increasing complexity of the healthcare sector requires an evolution in nursing education and clinical competencies to effectively manage care in complex and interdisciplinary contexts such as cardiology settings. methods this scoping review followed the joanna briggs institute framework. the preferred reporting items for systematic reviews and metaanalyses extension for scoping reviews prismascr was used to ensure rigorous and transparent reporting. results among the 647 records analyzed 15 were included in this review. in the cardiology setting the apn plays a critical role in clinical care education and research providing both direct and indirect support to patients at all stages across outpatient and inpatient settings. thanks to the advanced skills acquired through specific paths it also acts as a link between the healthcare team and patients improving the provision of care through personalized and coordinated actions and promoting continuous training and research in the field. conclusions apn enhances cardiac care by offering indepth clinical assessments education and support throughout the treatment process. however the lack of standardized regulatory frameworks in some countries limits the autonomy of cardiology apns within the healthcare system compromising their ability to address unmet healthcare needs and collaborate internationally. 2025 the authors. international nursing review published by john wiley sons ltd on behalf of international council of nurses. doi 10.1111inr.70054 pmcid pmc12206687 pmid 40583114 indexed for medline conflict of interest statement the authors declare no conflict of interest relevant to this article.",
    "7. g ital cardiol rome. 2025 jul267476487. doi 10.17144522.45222. the role of simulation in medical education clinical risk management and enhancing patient care in cardiology. article in italian zilio f1 giubilato s2 caldarola p3 ciliberti g4 di monaco a5 sorini dini c6 iannopollo g7 cornara s8 franchin l9 vitale e6 falsini g10 magnesa m11 fortuni f12 della bona r13 gatto l14 gasparetto n15 spinelli a16 roncon l17 cangemi s18 borrello f19 geraci g20 riccio c21 bilato c22 nardi f23 valente s6 rossini r24 gulizia mm25 gabrielli d26 colivicchi f16 grimaldi m5 oliva f27 a nome dellarea management e qualit dellarea giovani e del gruppo di studio responsabilit professionale e sicurezza delle cure anmco. author information 1u.o. cardiologia ospedale santa chiara apss trento. 2u.o.c. di utic con cardiologia ed emodinamica aoe cannizzaro catania. 3u.o. cardiologiautic ospedale san paolo bari. 4clinica di cardiologia e aritmologia aou ospedali riuniti umberto ilancisisalesi ancona. 5u.o.c. cardiologia ospedale miulli acquaviva delle fonti ba. 6u.o.c. cardiologia clinicochirurgicautic azienda ospedalierouniversitaria senese ospedale santa maria alle scotte siena. 7u.o.c. cardiologia ospedale maggiore bologna. 8s.c. cardiologia levante p.o. levante ospedale san paolo savona. 9dipartimento cardiotoracico ospedale santa maria della misericordia azienda sanitaria universitaria friuli centrale asufc udine. 10u.o.c. cardiologia valdarno usl toscana sud est montevarchi ar. 11u.o.c. cardiologiautic ospedale monsignor r. dimiccoli barletta bat. 12s.c. cardiologia e fisiopatologia cardiovascolare ospedale santa maria della misericordia universit degli studi perugia. 13u.o. cardiologia dipartimento cardiotoracovascolare dicatov ospedale policlinico san martino irccs irccs cardiovascular network genova. 14dipartimento cardiovascolare azienda ospedaliera san giovanni addolorata roma. 15u.o.c. cardiologia ospedale ca foncello treviso. 16u.o.c. cardiologia clinica e riabilitativa presidio ospedaliero san filippo neri asl roma 1 roma. 17u.o.c. cardiologia azienda ulss 5 polesana rovigo. 18u.o.s. emodinamica u.o.c. cardiologia ospedale san antonio abate asp trapani erice tp. 19divisione di cardiologia azienda ospedaliera pugliese ciaccio catanzaro. 20u.o. cardiologia ospedale santantonio abate asp trapani erice tp. 21u.o.s.d. followup del paziente postacuto dipartimento cardiovascolare a.o.r.n. santanna e san sebastiano caserta. 22u.o.c. cardiologia ospedali dellovest vicentino azienda ulss 8 berica vicenza. 23dipartimento di cardiologia ospedale santo spirito casale monferrato al. 24u.o.c. cardiologia azienda ospedaliera santa croce e carle cuneo. 25u.o.c. cardiologia ospedale garibaldinesima azienda di rilievo nazionale e alta specializzazione garibaldi catania. 26u.o.c. cardiologia dipartimento di scienze cardiotoracovascolari azienda ospedaliera san camillo forlanini roma. 27cardiologia 1emodinamica dipartimento cardiotoracovascolare a. de gasperis asst grande ospedale metropolitano niguarda milano presidente anmco associazione nazionale medici cardiologi ospedalieri firenze consigliere delegato per la ricerca fondazione per il tuo cuore heart care foundation firenze. in applied sciences including medicine simulation refers to a model of reality that employs a variety of techniques and technologies along with diverse professional expertise to facilitate the dynamic analysis and prediction of events or processes based on specific predefined conditions. simulation is of paramount importance to improve the skills of medical staff to speed up learning and to optimize clinical practice in different settings including cardiology. literature shows that simulation is more effective than other learning strategies supporting both upgrading of staffs clinical skills and patients safety reducing the risk of medical error. moreover andragogical principles highlight the need for personalized training programs in order to meet healthcare professionals needs while practicing in a safe environment improving technical skills clinical decision making stress management cooperation and teamwork. this review written by the management and quality working group by the young cardiologists working group and by the professional responsibility and safety of care study group of the the italian association of hospital cardiologists anmco highlights the crucial role of simulation in managing highrisk situations commonly encountered in cardiology emphasizing the importance of continuous highquality training. it also describes how anmco is promoting simulation as a strategy for implementing quality in the field of cardiology. doi 10.17144522.45222 pmid 40567190 indexed for medline",
    "8. zhonghua xin xue guan bing za zhi. 2025 jun 24536644652. doi 10.3760cma.j.cn1121482025022000132. current applications of large language models in clinical practice and needs assessment for cardiovascular physicians. article in chinese abstract available in chinese from the publisher wang wy1 wang zx1 zhao yz1 tian lx2 he l1 ma cs1. author information 1department of cardiology beijing anzhen hospital capital medical university beijing 100029 china. 2medlive technology co. ltd beijing 100024 china. objective to investigate the current awareness of large language models llm among chinese clinical physicians and analyze the application needs of cardiovascular specialists. methods this is a crosssectional study utilized convenience sampling. in december 2023 a selfdesigned questionnaire was distributed to 7 980 clinical physicians including 930 cardiologists. the survey collected demographic information including work city categorized as firsttier new firsttier secondtier thirdtier and fourthtier and below hospital level professional title and department. and the awareness of llm and their application demands in clinical decisionmaking support information filtering and scientific research work were also collected. differences in awareness and application requirements across geographic regions hospital tiers professional ranks and medical departments were analyzed. besides specific demands of cardiovascular specialists were further examined. results among the 7 980 clinical physicians the awareness rate of llm was 76.3 6 0887 980 and the utilization rate was 11.8 9427 980. for the 930 cardiologists the awareness rate was 78.5 730930 and the utilization rate was 11.4 106930. significant differences in awareness and utilization rates were observed across city tiers hospital grades and departments all p0.05. no significant difference was found among professional titles p0.053. among the 6 088 physicians aware of llm demand rates for clinical information filtering clinical decision support and research assistance were 87.3 5 3126 088 78.4 4 7746 088 and 75.8 4 6166 088 respectively. for the 730 cardiologists aware of llm these rates were 91.0 664730 79.2 578730 and 75.9 554730 respectively. significant differences in demands for clinical information filtering and research assistance were observed across city tiers hospital grades professional titles and departments all p0.05 while no significant difference was noted for decision support demands across hospital grades p0.085. in clinical information screening and acquisition cardiologists from different city tiers exhibited statistically significant differences in the demand for literature interpretation. similarly variations in the demand for conference summaries expert biographies healthcare policies and social news were noted among cardiologists with different professional titles while disparities in patient education and science popularization needs were identified across city tiers and hospital grades all p0.05. in clinical decisionmaking support cardiologists from diverse city tiers and professional titles demonstrated distinct differences in guideline and consensus inquiries and those from various city tiers showed varied demands for pharmaceutical and medical devicerelated content all p0.05. for research support cardiologists across city tiers and professional titles exhibited statistically significant differences in trial protocol design requirements while those from varying city tiers differed in literature searchanalysis and research application procedures. additionally physicians from different hospital grades displayed divergent needs for data collection all p0.05. conclusions the adoption of llm is significantly influenced by regional disparities institutional resources and professional backgrounds. implementing targeted interventions such as enhancing technical training optimizing llm functionalities and improving accessibility across diverse healthcare settings could encourage widespread integration of llm into clinical practice. such measures could ultimately enhance the quality and efficiency of medical services in china and foster innovations in healthcare delivery. publisher 2023127 980930 7 98076.36 0887 98011.89427 98093078.573093011.4106930p0.05p0.0536 08887.35 3126 08878.44 7746 08875.84 6166 08873091.066473079.257873075.9554730p0.05p0.085p0.05p0.05p0.05 . doi 10.3760cma.j.cn1121482025022000132 pmid 40528602 indexed for medline",
    "9. rev med liege. 2025 may8056354362. new recommendations from the european society of cardiology on chronic coronary syndromes. article in french abstract available in french from the publisher davin l1 carapelluci m1 piette c1 dulgheru re1 lancellotti p12. author information 1service de cardiologue chu lige belgique. 2giga cardiovasculaire et mtabolisme chu lige belgique. chronic coronary syndromes are a major public health issue worldwide characterized by a high prevalence and significant clinical consequences in terms of cardiovascular morbidity and mortality. the management of these syndromes has made considerable progress in recent decades due in particular to the development of more effective diagnostic strategies innovative therapeutic interventions and better targeted preventive measures. the european society of cardiology takes stock of the subject in its latest recommendations in 2024. publisher les syndromes coronariens chroniques constituent un enjeu de sant publique majeur lchelle mondiale caractriss par une prvalence leve et des consquences cliniques significatives en termes de morbidit et de mortalit cardiovasculaire. la prise en charge de ces syndromes a connu des avances considrables au cours des dernires dcennies en raison notamment de lessor de stratgies diagnostiques plus performantes dinterventions thrapeutiques innovantes et de mesures prventives mieux cibles. la socit europenne de cardiologie fait le point sur le sujet dans ses dernires recommandations en 2024. pmid 40518890 indexed for medline",
    "10. heart fail clin. 2025 jul213407415. doi 10.1016j.hfc.2025.01.011. what is new in risk assessment in nuclear cardiology gimelli a1 lakshmanan s2 della tommasina v3 liga r4. author information 1imaging department fondazione toscana gabriele monasterio via moruzzi 1 pisa italy. electronic address gimelliftgm.it. 2university of iowa hospitals and clinics 200 hawkins drive iowa city ia 52242 usa. 3cardiology unit ospedale versilia usl toscana nordovest ss1 via aurelia n. 335 55049 lido di camaiore lu italy. 4dipartimento di patologia chirurgica medica molecolare e dellarea critica university of pisa via savi 10 56126 pisa italy university hospital of pisa via savi 10 56126 pisa italy. nuclear cardiology techniques allow indepth evaluation of cardiac patients. a body of literature has established the use of nuclear cardiology. the results obtained with traditional cameras have been reinforced by those obtained with a series of innovations that have revolutionized the field of nuclear cardiology. this article highlights the role of nuclear cardiology in the risk assessment of patients with cardiac disease and sheds light on advancements of nuclear imaging techniques in the cardiovascular field. patient risk stratification has a key role in modern precision medicine. nuclear cardiac imaging techniques may quantitatively investigate major disease mechanisms of different cardiac pathologies. copyright 2025 elsevier inc. all rights reserved. doi 10.1016j.hfc.2025.01.011 pmid 40506154 indexed for medline",
    "11. heart fail clin. 2025 jul213361371. doi 10.1016j.hfc.2025.01.015. artificial intelligence in nuclear cardiology. miller rjh1. author information 1department of cardiac sciences university of calgary gaa08 3230 hospital drive northwest calgary alberta t2n 2t9 canada. electronic address robert.milleralbertahealthservices.ca. artificial intelligence ai encompasses a variety of computer algorithms that have a wide range of potential clinical applications in nuclear cardiology. this article will introduce core terminology and concepts for ai including classifications of ai as well as training and testing regimens. we will then highlight the potential role for ai to improve image registration and image quality. next we will discuss methods for aidriven image attenuation correction. finally we will review advancements in machine learning and deeplearning applications for disease diagnosis and risk stratification including efforts to improve clinical translation of this valuable technology with explainable ai models. copyright 2025 elsevier inc. all rights reserved. doi 10.1016j.hfc.2025.01.015 pmid 40506150 indexed for medline",
    "12. phys med. 2025 jul135105023. doi 10.1016j.ejmp.2025.105023. epub 2025 jun 11. local drl estimation and effective dose calculation in paediatric interventional cardiology using measurements and monte carlo simulations. teles p1 costa r2 bettio t2 pinheiro t3 loupa t4 santos j5 pinto f4 gil om6 ferrari p7 zankl m8. author information 1departamento de fsica e astronomia faculdade de cincias da universidade do porto rua do campo alegre sn 4169007 porto portugal centro de investigao do instituto portugus de oncologia do porto ciipop r. dr. antnio bernardino de almeida sn 4200072 porto portugal. electronic address pptelesfc.up.pt. 2departamento de fsica e astronomia faculdade de cincias da universidade do porto rua do campo alegre sn 4169007 porto portugal. 3instituto de bioengenharia e biocincias instituto superior tcnico universidade de lisboa av. rovisco pais 1 1049001 lisboa portugal departamento de engenharia e cincias nucleares instituto superior tcnico universidade de lisboa estrada nacional 10 km 1397 2695066 bobadela lrs portugal. 4centro hospitalar de lisboa central hospital de santa marta r. de santa marta 50 1169024 lisboa portugal. 5escola superior de tecnologia da sade de coimbra rua 5 de outubro 3046854 coimbra portugal. 6centro de cincias e tecnologias nucleares c2tn instituto superior tcnico universidade de lisboa estrada nacional 10 km 1397 2695066 bobadela lrs portugal departamento de engenharia e cincias nucleares instituto superior tcnico universidade de lisboa estrada nacional 10 km 1397 2695066 bobadela lrs portugal. 7italian national agency for new technologies energy and sustainable economic development enea bologna italy. 8helmholtz zentrum mnchen german research center for environmental health retired neuherberg germany. background paediatric patients with congenital heart disease benefit greatly from xray diagnostic and interventional procedures. however multiple procedures lead to prolonged exposure to ionizing radiation ir raising concerns for secondary longterm health issues. purpose this study aimed to establish local dose reference levels ldrls for a national reference center for congenital cardiopathies nrccc in portugal. additionally it estimated effective and organ doses in paediatric patients undergoing coronary angiographies cas using measurements and monte carlo simulations. methods ldrls were determined through statistical analysis of patient registry data from 120 patients recorded between 2022 and 2023. for effective dose estimation personal dose equivalent values hp10 were measured with an anthropomorphic phantom cirs atom 705 and raysafe dosimeters used to validate monte carlo mc simulations which were then employed with rescaled paediatric voxel phantoms gsf baby and child to estimate effective doses and dose conversion coefficients dccs for representative patient anatomies across different age and weight groups. results ldrls for coronary angiographies at the nrccc showed significant dose variability indicating dose optimization opportunities. monte carlo simulations allowed for organ dose and effective dose calculations. dose conversion coefficients were 1.107 0.882 0.719 and 0.524 msvgycm2 for newborn 1 yearold 5 yearold and 10 yearold groups respectively. a strong linear correlation between effective dose and airkerma area product kap was observed. conclusions the study highlights the strong correlation between effective dose and kap offering a practical framework for estimating patient doses and enhancing radiation safety protocols in clinical practice. copyright 2025 associazione italiana di fisica medica e sanitaria. published by elsevier ltd. all rights reserved. doi 10.1016j.ejmp.2025.105023 pmid 40505567 indexed for medline conflict of interest statement declaration of competing interest the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",
    "13. world j gastroenterol. 2025 jul 143126106509. doi 10.3748wjg.v31.i26.106509. risk factors and diagnostic biomarkers for asymptomatic immune checkpoint inhibitorrelated myocarditis in patients with esophageal cancer after immunotherapy. liu jy1 gao dl1 cao x2. author information 1department of cardiology the second hospital of shanxi medical university taiyuan 030001 shanxi province china. 2department of radiotherapy shanxi province cancer hospitalshanxi hospital affiliated to cancer hospital chinese academy of medical sciencescancer hospital affiliated to shanxi medical university taiyuan 030001 shanxi province china. cx18835129589163.com. background esophageal cancer is a serious global health concern with poor prognosis in advanced stages. immune checkpoint inhibitors icis have shown promise in enhancing survival but they are associated with immunerelated adverse events including potentially lifethreatening myocarditis. moreover iciinduced myocarditis can be asymptomatic necessitating early diagnosis. specific risk factors and biomarkers for esophageal cancer remain poorly characterized. aim to investigate the determinants of iciassociated asymptomatic myocarditis in patients with esophageal cancer and explore potential early biomarkers. methods a retrospective analysis was conducted on 202 cancer patients who received treatment at shanxi province cancer hospital from july 2019 to july 2024. results older age male gender and elevated creatine kinase isoenzymes ckmb and ck levels were found to be significant risk factors for asymptomatic myocarditis. the myocarditis occurrence group had higher ckmb 3.05 ngml vs 5.02 ngml p 0.001 and ck levels 187.29 ul vs 212.25 ul p 0.005 and the predictive value of age gender ck and ckmb was low are under the receiver operating characteristic curve auc 0.5790.608. however their combination in a predictive model showed improved diagnostic capability with an auc of 0.808. conclusion age gender and cardiac biomarker levels considerably contribute to the risk of icirelated myocarditis in patients with esophageal cancer. the integration of these factors into a predictive model enhances early diagnosis facilitating personalized risk management. the authors 2025. published by baishideng publishing group inc. all rights reserved. doi 10.3748wjg.v31.i26.106509 pmcid pmc12264808 pmid 40678710 indexed for medline conflict of interest statement conflictofinterest statement the authors declare that they have no conflict of interest.",
    "14. kyobu geka. 2025 jul787557561. surgery for cardiac rhabdomyosarcoma in jehovahs witnessesreport of a case. article in japanese tsunemoto h1 otsu y senda k. author information 1department of cardiovascular surgery aizawa hospital matsumoto japan. primary cardiac malignant neoplasms are rare and rhabdomyosarcoma is the second most common cardiac sarcoma. we herein report a rare case of 70yearold female with a cardiac rhabdomyosarcoma in the posterior wall of the left atrium. she was a member of jehovahs witnesses. we performed surgical tumor resection and mitral valve replacement because of apparent tumor invasion to the posterior leaflet of the mitral valve without blood transfusion. postoperative course was uneventful and she was scheduled to undergo proton beam therapy. this is the first case report of surgically treated cardiac rhabdomyosarcoma in a jehovahs witness. pmid 40676744 indexed for medline",
    "15. eur j med res. 2025 jul 18301639. doi 10.1186s4000102502911x. cryoballoon versus radiofrequency ablation for persistent atrial fibrillation an updated systematic review and metaanalysis. gao ym12 cai tz3 ma hl4. author information 1department of cardiovascular medicine the first affiliated hospital of xian medical university no.48 west road fenghao xian shaanxi 710077 china. 2xian medical university xian shaanxi china. 3department of cardiovascular medicine the first affiliated hospital of xian medical university no.48 west road fenghao xian shaanxi 710077 china. caitianzhi1978126.com. 4department of cardiovascular medicine the first affiliated hospital of xian medical university no.48 west road fenghao xian shaanxi 710077 china. mahlmed163.com. background compared with paroxysmal atrial fibrillation persistent atrial fibrillation af is more harmful and difficult to treat and the efficacy of different catheter ablation for both also varies greatly. so this study aimed to systematically evaluate the efficacy and safety of cryoballoon cb and radiofrequency rf ablation in the treatment of persistent af. methods we searched the pubmed embase and cochrane library databases for studies comparing the efficacy and safety between cb and rf ablation for persistent af. all included studies met our inclusion criteria. results a total of 11 studies 2551 patients were enrolled in this study including 1256 patients in cb group and 1295 patients in rf group. metaanalysis results showed that the freedom from atrial tachyarrhythmia ata recurrence was similar between the cb and rf groups or 1.00 95 ci 0.85 to 1.18 i2 16. the results of repeated ablation events in the two groups were similar or 0.85 95 ci 0.64 to 1.12 i245 while the operative time in the cb group was shorter than that in the rf group mean reduction 45.27 min 95 ci 61.34 to 29.20 min i2 95. there was no significant difference in fluoroscopy time between the two groups mean difference 2.12 min 95 ci 7.83 to 12.07 min i2 99. the incidence of total complications was similar between the two groups or 1.08 95 ci 0.74 to 1.58 i2 0 but phrenic nerve palsy pnp was more likely to occur in the cb group or 4.84 95 ci 1.84 to 12.71 i2 0. the incidence of pericardial tamponade was not statistically different between the two groups or 0.72 95 ci 00.32 to 1.58 i2 0. conclusions cb can be used as an alternative therapy to rf for persistent af both of which have considerable efficacy and safety. cb can significantly reduce the operation time with the probability of high pnp. 2025. the authors. doi 10.1186s4000102502911x pmid 40676688 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate there are no ethical issues involved in this metaanalysis. competing interests the authors declare no competing interests.",
    "16. bmc pediatr. 2025 jul 17251557. doi 10.1186s12887025058913. clinical analysis of karyotypes and phenotypes in 87 cases of turner syndrome during transitional period. luo j1 yang l2 guo h3 yao h4 chen x1 feng l1. author information 1department of endocrinology and metabolism wuhan childrens hospital tongji medical college huazhong university of science and technology wuhan china. 2department of endocrinology and metabolism wuhan childrens hospital tongji medical college huazhong university of science and technology wuhan china. yangluhongzgwhfe.com. 3department of general surgery wuhan childrens hospital tongji medical college huazhong university of science and technology wuhan china. 4department of endocrinology and metabolism wuhan childrens hospital tongji medical college huazhong university of science and technology wuhan china. yaohuizgwhfe.com. objective this study aimed to analyze the phenotypic characteristics of patients with turner syndrome ts during the transitional period 1218 years and explore associations between clinical manifestations laboratory findings imaging features and karyotypic variations thereby optimizing clinical management strategies. methods chromosomal gbanding was performed on 87 patients with ts admitted to wuhan childrens hospital between january 2008 and december 2024. patients were divided into group a cases with x monosomy 45 x and group b cases with other x chromosomal abnormalities including mosaicism and structural anomalies. the clinical laboratory and imaging features were compared between the two groups. results among the 87 patients 43 49.43 were diagnosed with x monosomy whereas 44 50.57 exhibited other x chromosomal abnormalities including 2 cases 2.29 with y chromosome material. group a exhibited significantly higher rates of facial dysmorphism 95.35 versus 59.09 p 0.001 cardiovascular anomalies 41.86 versus 18.18 p 0.016 spinal deformities 58.14 versus 34.09 p 0.024 renal abnormalities 27.91 versus 4.55 p 0.003 and elevated fasting insulin levels median 9.2 versus 6.7 miuml p 0.007 compared to group b. conclusions patients with transitional ts exhibit diverse karyotypes with x monosomy may be associated with more severe phenotypes. karyotype evaluation may help inform individualized monitoring priorities particularly for cardiovascular renal and metabolic comorbidities. these findings support individualized clinical management and multidisciplinary transitional care informed by karyotype. 2025. the authors. doi 10.1186s12887025058913 pmid 40676636 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate the ethic was approved by the institutional review boardethics committee of wuhan childrens hospital approval no. 2025r037e01 based on the principles of the declaration of helsinki. this study is of the type of data analysis rather than a clinical trial so clinical trial number was not applicable. this study was informed consent was obtained from all participants andor their legal guardians. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "17. biol sex differ. 2025 jul 1716153. doi 10.1186s13293025007272. electrocardiographic sex index a continuous representation of sex. karabayir i1 celik t1 patterson l1 butler l1 herrington d1 akbilgic o2. author information 1department of cardiovascular medicine wake forest school of medicine winston salem nc 27157 usa. 2department of cardiovascular medicine wake forest school of medicine winston salem nc 27157 usa. oguz.akbilgicadvocatehealth.org. clinical risk calculators consider sex as a binary variable. however sex is a complex trait with anatomic physiologic and metabolic attributes that are not easily summarized in this manner 1. we propose a continuous representation of sex the ecg sex index esi derived via artificial intelligence analyses of electrocardiograms ecgai.we used an ecg repository at wake forest baptist health winstonsalem nc to develop a convolutional neural networkbased ecgai model to detect sex from standard 12lead ecgs. we utilized a rankordered transformation of the outcomes of ecgai to create the esi. we also created a sex discordance index sdi from the esi and assessed its utility in 1year risk prediction for allcause mortality heart failure and kidney failure.the wake forest cohort included 3573844 ecgs and electronic health record data from 754761 patients 75 were white 17 were black and 51 were female with a mean age sd of 61 17 years. the physionet external validation cohort included 45152 ecgs from 10646 patients from two hospitals in china. the physionet cohort was 100 asian 43.6 female and had a mean age sd of 59 20 years. ecgai provided a holdout area under the curve of 0.95 and an external validation area under the curve of 0.92. lower esi scores in males and higher esi scores in females were associated with a greater risk for clinical outcomes. the esi and sdi demonstrated comparable accuracy to binary sex in logistic regression analyses and outperformed binary sex in predicting clinical outcomes highlighting their value as predictors in risk calculators for allcause mortality heart failure and kidney failure. plain language summary an individuals sex is typically classified as male or female at birth based on the presence of either a penis or a clitoris. however there are many common features of male and female individuals at the metabolic and cellular levels. these commonalities are neglected in disease risk prediction models when an individual is labeled as male or female. this study proposes a novel nonbinary representation of sex to be used in disease risk prediction models. our novel nonbinary variable is derived via artificial intelligence applied to electrocardiographic data. it predicts allcause mortality heart failure and kidney failure better than a binary sex variable. 2025. the authors. doi 10.1186s13293025007272 pmid 40676621 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this study was approved by the wake forest baptist health irb irb00079984. as a retrospective analysis of data with exempt status we did not obtain consent from individuals. consent for publication all the authors have approved this submission. competing interests the authors declare no competing interests.",
    "18. bmc neurol. 2025 jul 17251294. doi 10.1186s12883025043061. safety and effectiveness of rivaroxaban dabigatran and apixaban in patients with nonvalvular atrial fibrillation for stroke prophylaxis. tanolu c1 ersoy a2. author information 1department of neurology health sciences university izmir tepecik education and research hospital izmir turkey. ceydatanoglugmail.com. 2department of neurology faculty of medicine erzincan binali yldrm university erzincan turkey. background atrial fibrillation is the most common arrhythmia that causes an increased risk of thromboembolism. we aimed to evaluate stroke and major bleeding risk in patients with atrial fibrillation using rivaroxaban apixaban dabigatran and the effects of using antiplatelet atorvastatin and proton pump inhibitor ppi on development of stroke. methods patients who were administered rivaroxaban dabigatran or apixaban for atrial fibrillation between june 2014 and december 2020 were retrospectively analysed. demographic data chads2 and cha2ds2vasc scores hasbled scores antiplatelet proton pump inhibitor atorvastatin medications were evaluated. furthermore we evaluated the risk of major bleeding and stroke during treatment. results we investigated 162 patients using dabigatran 255 patients using rivaroxaban and 104 patients using apixaban. no significant difference was observed between the groups in terms of cha2ds2vasc scores and the use of atorvastatin proton pump inhibitor and antiplatelet. hasbled scores before doacs treatment were statistically significantly higher in the apixaban group compared to rivaroxaban and dabigatran groups p 0.038 we found no difference between the study groups in terms of major bleeding p 0.528 and stroke risk p 0.498. the use of antiplatelet proton pump inhibitor and atorvastatin did not have a significant effect on stroke risk p 0.533 p 0.169 and p 0.949. conclusion rivaroxaban dabigatran and apixaban have similar safety and efficacy for stroke prophylaxis. the use of antiplatelet proton pump inhibitor and atorvastatin did not have a significant effect on stroke risk. 2025. the authors. doi 10.1186s12883025043061 pmid 40676530 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate ethics committee of erzincan binali yldrm university approval code 20232214 and was performed in accordance with the declaration of helsinki. informed consent form was signed by all participants. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "19. bmc nephrol. 2025 jul 17261394. doi 10.1186s12882025043248. a change of heart the effect of high flow arteriovenous fistulas on cardiovascular outcomes a systematic review and synthesis without metaanalysis swim. shah na123 hind me4 endre zh56 cochran bj7 barber tj8 erlich jh56. author information 1school of clinical medicine faculty of medicine health unsw sydney sydney nsw australia. nasir.shahhealth.nsw.gov.au. 2department of nephrology prince of wales hospital sydney nsw australia. nasir.shahhealth.nsw.gov.au. 3department of nephrology the sutherland hospital sydney nsw australia. nasir.shahhealth.nsw.gov.au. 4school of medicine university of notre dame australia sydney nsw australia. 5school of clinical medicine faculty of medicine health unsw sydney sydney nsw australia. 6department of nephrology prince of wales hospital sydney nsw australia. 7school of biomedical sciences faculty of medicine health unsw sydney sydney nsw australia. 8school of mechanical and manufacturing engineering faculty of engineering unsw sydney sydney nsw australia. background and hypothesis although arteriovenous fistulas avf are widely accepted as the gold standard form of dialysis access for haemodialysis patients high avf flow may impose significant haemodynamic stress potentially contributing to adverse cardiovascular events including heart failure hf. we hypothesize that higher avf flow is associated with adverse cardiovascular outcomes including an increased incidence of heart failure. we sought to clarify this relationship as understanding this association is crucial for improving patient care. methods a comprehensive search of the pubmed embase and cochrane databases was used to identify observational studies and randomized controlled trials reporting an effect of avf flow on cardiac outcomes clinical echocardiographic and biomarker. due to study heterogeneity metaanalysis was not feasible. synthesis without metaanalysis swim was performed using vote counting of direction of effect as the primary outcome. results higher avf flow rates were consistently associated with increased incidence of hf and worsening hf symptoms. cardiac imaging revealed left ventricular dilation and reduced left ventricular ejection fraction in patients with highflow avfs. elevated biomarkers such as natriuretic peptides corroborated the adverse cardiovascular effects of high avf flow. conclusions this systematic review and synthesis without metaanalysis showed a positive relationship between avf flow and clinical echocardiographic and biomarker cardiovascular outcomes. the methodological heterogeneity of studies highlights the need for welldesigned prospective research with standardised definitions of high flow avfs and measures for reporting of cardiovascular outcomes. 2025. the authors. doi 10.1186s12882025043248 pmid 40676508 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this study is a systematic review and did not involve the recruitment of human participants or the collection of primary data. as such ethical approval and informed consent were not required. competing interests the authors declare no competing interests.",
    "20. arch osteoporos. 2025 jul 17201100. doi 10.1007s11657025015794. opportunistic computed tomography ct assessment of osteoporosis in patients undergoing transcatheter aortic valve replacement tavr. paukovitsch m1 fechner t2 felbel d3 moerike j3 rottbauer w3 klmpken s2 brunner h2 kloth c2 beer m24 sekuboyina a56 buckert d3 kirschke js6 sollmann n78910. author information 1department of cardiology ulm university heart center alberteinsteinallee 23 89081 ulm germany. michael.paukovitschuniklinikulm.de. 2department of diagnostic and interventional radiology university hospital ulm alberteinsteinallee 23 89081 ulm germany. 3department of cardiology ulm university heart center alberteinsteinallee 23 89081 ulm germany. 4moman center for translational imaging university hospital ulm einsteinallee 23 89081 ulm germany. 5department of informatics information and technology tum school of computation technical university of munich arcisstr. 21 80333 munich germany. 6department of diagnostic and interventional neuroradiology school of medicine and health tum klinikum rechts der isar technical university of munich ismaninger str. 22 81675 munich germany. 7department of diagnostic and interventional radiology university hospital ulm alberteinsteinallee 23 89081 ulm germany. nico.sollmanntum.de. 8department of diagnostic and interventional neuroradiology school of medicine and health tum klinikum rechts der isar technical university of munich ismaninger str. 22 81675 munich germany. nico.sollmanntum.de. 9tumneuroimaging center tum klinikum rechts der isar technical university of munich 81675 munich germany. nico.sollmanntum.de. 10department of nuclear medicine university hospital ulm alberteinsteinallee 23 89081 ulm germany. nico.sollmanntum.de. ctbased opportunistic screening using artificial intelligence finds a high prevalence 43 of osteoporosis in ct scans obtained for planning of transcatheter aortic valve replacement. thus opportunistic screening may be a costeffective way to assess osteoporosis in highrisk populations. background osteoporosis is an underdiagnosed condition associated with fractures and frailty but may be detected in routine computed tomography ct scans. methods volumetric bone mineral density vbmd was measured in clinical routine thoracoabdominal ct scans of 207 patients for planning of transcatheter aortic valve replacement tavr using an artificial intelligence aibased algorithm. results 43 of patients had osteoporosis vbmd 80 mgcm3 l1l3 and were elderly 83.0 interquartile range iqr 78.085.5 vs. 79.0 iqr 71.884.0 years p 0.001 more often female 55.1 vs. 28.8 p 0.001 and had a higher society of thoracic surgeons score for mortality 3.0 iqr1.84.6 vs. 2.1 iqr 1.43.2 p 0.001. in addition to lumbar vbmd 58.2 14.7 vs. 106 21.4 mgcm3 p 0.001 thoracic vbmd 79.5 17.9 vs. 127.4 26.0 mgcm3 p 0.001 was also significantly reduced in these patients and showed high diagnostic accuracy for osteoporosis assessment area under curve 0.96 p 0.001. osteoporotic patients were significantly more often at risk for falls 40.4 vs. 22.9 p 0.007 and required help in activities of daily life adl more frequently 48.3 vs. 33.1 p 0.026 while directtohome discharges were fewer 88.8 vs. 96.6 p 0.026. inhospital bleeding complications 3.4 vs. 5.1 stroke 1.1 vs. 2.5 and death 1.1 vs. 0.8 were equally low while inhospital device success was equally high 94.4 vs. 94.9 p 0.05 for all comparisons. however oneyear probability of survival was significantly lower 84.0 vs. 98.2 logrank p 0.01. conclusion applying an aibased algorithm to tavr planning ct scans can reveal a high rate of 43 patients having osteoporosis. osteoporosis may represent a marker related to frailty and worsened outcome in tavr patients. 2025. the authors. doi 10.1007s11657025015794 pmid 40676440 indexed for medline conflict of interest statement declarations. ethical approval all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. conflict of interest jan s. kirschke and anjany sekuboyina have equity in bonescreen gmbh. michael paukovitschtom fechner dominik felbel johannes moerike wolfgang rottbauer steffen klmpken horst brunner christopher kloth meinrad beer dominik buckert and nico sollmann declare they have no relevant conflict of interest.",
    "21. curr rheumatol rep. 2025 jul 1727131. doi 10.1007s1192602501190z. cardiac manifestations in behets syndrome. bello f1 bagni g12 seyahi e3 chiara e14 olivotto i15 saadoun d6 emmi g78. author information 1department of experimental and clinical medicine university of florence italy and internal interdisciplinary unit behet centre careggi university hospital florence italy. 2department of clinical and biological sciences university of turin turin italy. 3division of rheumatology department of internal medicine and behets disease research centre istanbul universitycerrahpasa school of medicine istanbul turkey. 4department of medical surgical and health sciences university of trieste italy and clinical medicine and rheumatology unit cattinara university hospital trieste italy. 5meyer childrens hospital irccs florence italy. 6department of internal medicine and clinical immunology sorbonne university groupe hospitalier pitisalptrire assistance publiquehpitaux de paris aphp 75013 paris france. 7department of medical surgical and health sciences university of trieste italy and clinical medicine and rheumatology unit cattinara university hospital trieste italy. giacomo.emmiunits.it. 8centre for inflammatory diseases monash university department of medicine monash medical centre melbourne australia. giacomo.emmiunits.it. purpose of the review behets syndrome bs is a multisystemic vasculitis that can affect the heart leading to pericarditis myocarditis intracardiac thrombosis endomyocardial fibrosis valvular dysfunction and coronary artery disease. this review summarizes the clinical presentation diagnostic challenges and therapeutic strategies for cardiac involvement in bs. recent findings advanced imaging techniques have revealed subclinical cardiac involvement in bs. myocardial dysfunction and fibrosis contribute to heart failure and arrhythmias while intracardiac thrombi often coexist with pulmonary artery involvement. coronary artery vasculitis and aneurysms may mimic atherosclerotic disease complicating diagnosis. biologic therapies including tnf inhibitors show promise in refractory cases. early diagnosis and immunosuppressive therapy are crucial. a multidisciplinary approach is essential to managing cardiac complications and optimizing patient outcomes. future research should refine screening protocols and explore targeted immunotherapies for bsrelated cardiovascular disease. 2025. the authors. doi 10.1007s1192602501190z pmid 40676431 indexed for medline conflict of interest statement declarations. competing interests the authors declare no competing interests. human and animal rights and informed consent this article does not contain any studies with human or animal subjects performed by any of the authors.",
    "22. radiologia engl ed. 2025 julaug674101639. doi 10.1016j.rxeng.2025.101639. epub 2025 jun 7. sudden cardiac death risk stratification using cardiac mri. domenechximenos b1 jimnezarjona r2 ortizprez jt3 perea rj2 snchez m2 pratgonzlez s3 doltra a3. author information 1departamento de radiologa centro de diagnstico por la imagen cdi hospital clnic barcelona spain. electronic address bl.domenechgmail.com. 2departamento de radiologa centro de diagnstico por la imagen cdi hospital clnic barcelona spain. 3departamento de cardiologa instituto clnic cardiovascular iccv hospital clnic barcelona spain. sudden cardiac death scd is recognised as a public health problem and can be caused by multiple heart diseases which vary depending on the age of the patient. scd risk stratification is a controversial topic surrounded by debate since it is not easy to determine the appropriate timing for implanting an automatic defibrillator. given that arrhythmic events are associated with myocardial scars scd stratification should go beyond the assessment of systolic function. cardiac magnetic resonance imaging mri plays a fundamental role since it enables the noninvasive characterisation of macroscopic and interstitial myocardial fibrosis revealing the pattern and extent. this article reviews the role of cardiac mri in scd risk prediction. copyright 2024 seram. published by elsevier espaa s.l.u. all rights reserved. doi 10.1016j.rxeng.2025.101639 pmid 40675721 indexed for medline conflict of interest statement declaration of competing interest all the authors declare that they have no conflicts of interest.",
    "23. biomed res int. 2025 jul 920259973081. doi 10.1155bmri9973081. ecollection 2025. capillary blood selfsampling for therapeutic drug monitoring a mixedmethods usability study of the true dose kit. crafoord mt1 hedayati e23 johnsson a2. author information 1department of clinical science and education sdersjukhuset south hospital karolinska institutet stockholm sweden. 2department of oncologypathology karolinska institutet stockholm sweden. 3department of oncology sdersjukhuset south hospital stockholm sweden. objective this study evaluates the usability in accordance with en 62366 of the true dose kit for capillary blood selfsampling to be used to analyze specify design verify and validate usability as it relates to the safety of medical devices focusing on user performance experience and user confidence through a mixedmethods approach. the usability engineering process is needed to fulfill user interface design requirements as part of product development at true dose kit. methods the study employed a convergent parallel design integrating quantitative and qualitative data. twentyfive participants recruited through convenience sampling used the true dose kit to perform capillary blood selfsampling. quantitative data were collected using three key performance metricscollection of sufficient blood volume absence of air bubbles and duration of the selfsampling processalong with two questionnaires the system usability scale sus and the test feedback questionnaire tfq to comprehensively assess user performance and experience. in contrast qualitative data were obtained from interviews and freetext responses. the integration of findings highlighted areas of convergence and divergence between the quantitative and qualitative data. results the overall sus score was 82.70 indicating high usability. however participants reported challenges with the complexity of instructions and stress associated with blood flow management. qualitative insights revealed a preference for simplified visual guidance and highlighted the need for precise feedback mechanisms to ensure the correct execution of sampling steps. despite these challenges 92 of participants collected the required blood sample with a median selfsampling duration of 10.42 min. conclusion the true dose kit demonstrates high usability potential but improvements in instructional design and stress management are needed to enhance user experience and ensure consistent performance. trial registration euct number 20245148181200. copyright 2025 marietherse crafoord et al. biomed research international published by john wiley sons ltd. doi 10.1155bmri9973081 pmcid pmc12267959 pmid 40678388 indexed for medline conflict of interest statement e.h. is the cofounder and a board member of true dose ab a medtech company that develops athome blood sampling kits. this role could be perceived as a potential conflict of interest due to the relevance of the companys products to the research topic. e.h. has also received speaker and consultancy fees from bristolmyers squibb pfizer and amgen with all payments made to karolinska university hospital. these relationships are unrelated to the current study. the other authors declare no conflicts of interest.",
    "24. microcirculation. 2025 jul325e70018. doi 10.1111micc.70018. mechanically tunable polyethylene glycol diacrylate hydrogels reveal stiffnessrelated impairments in capillary sprouting in experimental lung fibrosis. leonardduke j12 agro smj3 csordas dj12 hannan rt24 bruce ac1 sturek jm4 peirce sm12 taite lj3. author information 1department of biomedical engineering university of virginia charlottesville virginia usa. 2robert m. berne cardiovascular research center university of virginia charlottesville virginia usa. 3department of chemical engineering university of virginia charlottesville virginia usa. 4department of pulmonary and critical care medicine university of virginia charlottesville virginia usa. objective synthetic hydrogels that support 3d cell culture are widely used as platforms for modeling disease such as tissue fibrosis which leads to mechanical stiffening of the extracellular matrix ecm. to interrogate how mechanical stiffness of the ecm affects microvascular remodeling we developed a bioactive polyethylene glycol diacrylate pegda hydrogel model with tunable stiffness that permits microvascular sprouting. methods lung explants harvested from healthy and fibrotic mice were cultured ex vivo on pegda hydrogels for 7 days. capillary sprouting from lung segments was evaluated via imaging and secreted angiogenic markers. results healthy lung explants had decreased sprout formation and length on stiffer hydrogels. the sprouts from fibrotic lung explants however were not impacted by hydrogel stiffness. this difference was associated with higher expression of angiogenic markers and matrix remodeling enzymes in the fibrotic lung explants. conclusions our results suggest a compensation in vasculature derived from fibrotic tissue to matrix mechanics in promoting angiogenic sprouting. 2025 the authors. microcirculation published by john wiley sons ltd. doi 10.1111micc.70018 pmid 40677170 indexed for medline",
    "25. vet med sci. 2025 jul114e70455. doi 10.1002vms3.70455. ultrasonographic measurement of the renal cortical thicknesstoabdominal aortic ratio in healthy rabbits. yousefsani zs1 mirshahi a2 azizzadeh m2 khorasani an1. author information 1private veterinarian mashhad iran. 2faculty of veterinary medicine department of clinical sciences ferdowsi university of mashhad mashhad iran. background ultrasonography is a preferred diagnostic tool for renal disease in clinical practice. kidney size is a commonly used morphological parameter in renal assessment however it lacks sensitivity for early disease detection. cortical parameters particularly cortical thickness correlate more strongly with early renal disease as the cortex plays a key role in filtration and is highly vulnerable to injury. rabbits widely kept as pets have distinct renal anatomy and are prone to kidney diseases making them a relevant model for renal studies. previous studies have shown that ultrasonography can effectively measure kidney size in rabbits correlating with body weight. objectives this study aimed to establish a normative ratio of renal cortical thickness to the internal diameter of the abdominal aorta in healthy rabbits. methods sixty healthy adult male mixedbreed rabbits underwent ultrasonographic evaluation. renal cortical thickness and abdominal aortic diameter were measured ensuring that only rabbits without clinical or ultrasonographic signs of kidney disease were included. results pearson correlation analysis revealed a positive correlation between renal cortical thickness aortic diameter and body weight. however the ratio of renal cortical thickness to aortic diameter remained independent of body weight. conclusions this study established a normative reference range for renal cortical thickness relative to aortic diameter in rabbits providing a novel diagnostic parameter for renal assessment. the confidence intervals for the ratio were 0.82 0.770.87 to 1.35 1.301.40 for the left kidney and 0.79 0.740.84 to 1.33 1.271.38 for the right kidney marking the first report of this method in the literature. 2025 the authors. veterinary medicine and science published by john wiley sons ltd. doi 10.1002vms3.70455 pmid 40677103 indexed for medline",
    "26. kyobu geka. 2025 jul787562566. distal stent graftinduced new entry on the lesser curvature of distal aortic archreport of a case. article in japanese saga t1 koga m izuka s miyagawa h. author information 1department of cardiovascular surgery kanto central hospital tokyo japan. a 62yearold male was admitted for cerebral hemorrhage enhanced computed tomography ct revealed a dissecting thoracic aortic aneurysm in the distal arch. following cerebral hemorrhage treatment the patient was referred to our department and underwent a total arch replacement using the frozen elephant trunk fet technique. the patient was followed up regularly post operatively at our hospital. enhanced ct at 31 months post surgery revealed a distal stent graftinduced new entry dsine on the lesser curvature of the distal arch. additional thoracic endovascular aortic repair tevar was performed. although dsine can be caused by various factors it is usually seen on the greater curvature of the aorta and is relatively rare on the lesser curvature as in this case in japan. we will discuss the mechanisms underlying the development of dsine on the lesser curvature with reference to the literature. pmid 40676745 indexed for medline",
    "27. kyobu geka. 2025 jul787551555. anterolateral partial sternotomy as an effective approach for open repair after debranching thoracic endovascular aortic repair in aortic arch aneurysm. article in japanese sato m1 hayashi t taniguchi s goto t. author information 1department of cardiovascular surgery japanese red cross kyoto daini hospital kyoto japan. thoracic endovascular aortic repair tevar has become a common minimally invasive option for aortic surgery often accompanied by debranching of the aortic arch branches. however tevarspecific complications occasionally necessitate open repair. in such cases especially in patients with complex aortic arch pathology the choice of surgical approach is critical. in this case considering the unique background of cold agglutinin disease we opted for an anterolateral partial sternotomy approach. this approach provided excellent exposure for aortic manipulation and allowed preservation of the existing bypass grafts contributing to a successful outcome. we believe that this technique can be effectively applied in similar complex cases requiring open repair after debranching tevar. pmid 40676743 indexed for medline",
    "28. bmc anesthesiol. 2025 jul 17251350. doi 10.1186s12871025032273. effects of liquid resuscitation guided by internal jugular vein variability during deep inhalation on preventing propofolinduced hypotension in elderly patients. wei xl1 xi yz1 xie l1 li zp1 tang hl1 zhou qh2. author information 1department of anesthesiology and pain medicine the affiliated hospital of jiaxing university no.1882 ring 2nd south road jiaxing city 314000 zhejiang province china. 2department of anesthesiology and pain medicine the affiliated hospital of jiaxing university no.1882 ring 2nd south road jiaxing city 314000 zhejiang province china. zqh10980zjxu.edu.cn. background methods for reliably predicting hypotension in patients during general anesthesia induction are currently lacking. deep inhalation has been shown to enhance the variability of the internal jugular vein ijv. in this study we aim to investigate the relationship between internal jugular vein variability ijvv during deep inhalation and the extent of blood pressure decrease during propofol induction as well as the potential of utilizing ijvv as a guide for preanesthesia fluid resuscitation. methods before general anesthesia induction bedside ultrasonic measurement was performed to evaluate the maximum diameter ijvmaxd and minimum diameter ijvmind of the ijv and the maximum crosssectional area ijvmaxa and minimum crosssectional area ijvmina and then calculated the ijv diameter variability ijvvd and ijv area variability ijvva. a receiver operating characteristic roc curve was used to determine the diagnostic value of ijvvd and ijvva for predicting propofol induced hypotension blood pressure decreased 20 and calculate the cutoff value. the following prospective randomized controlled trial aimed to compare the incidence of anesthesiainduced hypotension between the ijvvd or ijvva guided fluid administration group a and the standard fluid administration group group b in patients with the variability value optimal cutoff value. the occurrence rate of hypotension during the propofol induction period was observed and compared between the two groups. results a total of 60 patients were included in the final analysis. a significant strong correlation exists between ijvva and the degree of blood pressure decrease during deep inhalation r 0.858 p 0.001. the auc of ijvva was 0.900 95 ci 0.8210.979 p 0.001 with a cutoff value of 23.42 sensitivity 81.5 specificity 84.8. at the same time a total of 87 patients with ijvva 23.42 during deep inhalation were included in the data analysis. the incidence of hypotension in group a was 26.8 compared to 63.0 in group b revealing a statistically significant difference p 0.001. conclusions a significant relationship was observed between ijvv levels during deep inhalation and the blood pressure decline following propofol induction. administering ijvva guided fluid infusion can significantly reduce propofolinduced hypotension by keeping the ijvva less than 23.42 during deep inspiration. trial registration successfully registered on clinicaltrials.gov on november 1 2023 nct06112769 and on august 1 2024 nct06641505. 2025. the authors. doi 10.1186s12871025032273 pmid 40676549 indexed for medline conflict of interest statement declarations. ethics approval and informed consent. this trial was approved by the ethics committee of the affiliated hospital of jiaxing university china on october 24th 2023 ls2023ky603 before the experiment was started and that has been conducted following the principles outlined in the helsinki declaration. written informed consent was obtained from all participants or their guardians. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "29. bmc anesthesiol. 2025 jul 17251348. doi 10.1186s12871025032282. distal versus conventional radial artery catheterization for hemodynamic monitoring in intensive care setting a randomized controlled noninferiority trial. peng c123 wu w13 zhang y13 han z13 deng x13 tan j13 xi z45 zhang r67. author information 1department of emergency and critical care medicine yichang central peoples hospital yichang 443003 hubei china. 2department of nursing yichang central peoples hospital yichang 443003 hubei china. 3the first college of clinical medical science china three gorges university yichang 443003 hubei china. 4department of nursing yichang central peoples hospital yichang 443003 hubei china. xizuyang0501163.com. 5the first college of clinical medical science china three gorges university yichang 443003 hubei china. xizuyang0501163.com. 6department of emergency and critical care medicine yichang central peoples hospital yichang 443003 hubei china. zhangrong20240304163.com. 7the first college of clinical medical science china three gorges university yichang 443003 hubei china. zhangrong20240304163.com. contributed equally background arterial catheterization is fundamental for hemodynamic monitoring in critically ill patients yet instability and loss of arterial pressure waveform remain clinically significant issues. the distal radial artery dra approach has been proposed as a potential alternative to the conventional radial artery ra approach. this is the first randomized clinical trial to assess the comparative efficacy and reliability of dra versus ra catheterization by examining firstattempt success rates and the stability of arterial pressure waveforms in critically ill icu patients. methods this randomized controlled trial enrolled 200 critically ill patients requiring arterial catheterization assigning them to either dra n 100 or conventional ra n 100 groups. all procedures utilized a standard 20gauge polyurethane peripheral intravenous catheter. coprimary outcomes included firstattempt success rate and frequency of arterial pressure waveform loss during the initial 72h period. secondary outcomes included catheterization time complications during insertion and management hemostasis time and catheter duration. bonferroni correction was applied for multiple testing 0.025. results firstattempt success rates were comparable between dra and ra groups 86 vs. 84 p 0.688. the dra group experienced significantly fewer arterial pressure waveform losses across all three days day 1 1.0 0.0 2.0 vs. 2.0 1.0 2.0 day 2 1.0 0.0 1.0 vs. 2.0 1.0 2.0 day 3 0.0 0.0 1.0 vs. 1.0 1.0 2.0 all p 0.001. both groups achieved 100 procedural success with no site crossovers. arterial catheterization time was longer in the dra group p 0.001. complication rates during catheterization management and after removal were similar between groups. hemostasis time was significantly shorter in the dra group 2.6 1.5 min vs. 4.2 0.9 min p 0.001. catheter duration was similar between groups 76.6 16.7 vs. 77.4 16.4 h p 0.724. conclusions while firstattempt success rates were similar the dra approach offered greater arterial pressure waveform stability and shorter hemostasis time than the conventional ra approach without increasing complications. thus dra may be a preferable option for arterial catheterization in critically ill patients. trial registration this study is registered in the chinese clinical trials registry registration number chictr2400086284 registration date 27062024. 2025. the authors. doi 10.1186s12871025032282 pmid 40676532 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this randomized controlled trial was approved by the ethics committee of the first college of clinical medical science of china three gorges university ethical approval number 202313001. this trial was prospectively registered at the chinese clinical trial registry chictr2400086284 registered 27062024. written informed consent was obtained from all participants or their legally authorized representatives prior to randomization and study procedures. this study was conducted in accordance with the declaration of helsinki and followed the consort guidelines for reporting randomized trials. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "30. fish physiol biochem. 2025 jul 17514121. doi 10.1007s10695025015338. physiology and morphology of clonal atlantic salmoninfluence of incubation temperature ploidy and zygosity. hvas m1 warrenmyers f2 johansen ib3 fjelldal pg4 hansen tj4. author information 1animal welfare research group institute of marine research matre norway. malthe.hvashi.no. 2sustainable aquaculture laboratory temperate and tropical saltt deakin university geelong australia. 3department of preclinical sciences and pathology faculty of veterinary medicine norwegian university of life sciences oslo norway. 4reproduction and developmental biology institute of marine research matre norway. isogenic clonal fish lines are useful experimental models to study effects of environment versus genetics on phenotypic traits as they can be maintained for generations without change providing advantages over outbred groups prone to generational change and higher variation. here we performed experiments on isogenic atlantic salmon groups that were either heterozygous diploid homozygous diploid triploid or heterozygous diploid incubated at 4 c instead of 8 c. we measured metabolic rates stress response and hypoxia tolerance to assess wholeanimal performance traits. then we measured the morphology of hearts and otoliths since both are known to be influenced by environmental history. isogenic ploidy and zygosity statuses were confirmed from microsatellite markers. embryonic development is affected by temperature hence the 4 c incubation group was tested 9 months later when it had reached an equivalent size as the other groups. curiously a bimodal size distribution emerged in this group. physiological traits were similar between groups apart from higher standard metabolic rates in the 4 c incubated fish. each group had distinct heart morphologies where fish with a slower growth history resembled wildphenotypes while homozygous fish had the most deviating hearts. proportions of vaterite deposition in otoliths showed high individual variation and did not differ between groups. lower coefficients of variation within groups were found when compared to outbred fish but this was not consistent for all traits assessed. as such substantial phenotypic variation in physiology and morphology was still observed in isogenic atlantic salmon which can be ascribed to random environmental factors. 2025. the authors. doi 10.1007s10695025015338 pmid 40676254 indexed for medline conflict of interest statement declarations. competing interests the authors declare no competing interests.",
    "31. nat commun. 2025 jul 181616609. doi 10.1038s4146702561903x. silicon nanocolumnbased disposable and flexible ultrasound patches. kang dh12 cho s13 kim hy1 shim s1 kim dh1 jeong b4 lee ys4 park ea4 lee w4 kim h1 khuriyakub bt5 im m678 jeong jw9 lee bc101112. author information 1bionics research center korea institute of science and technology seongbukgu seoul republic of korea. 2department of mechanical engineering gangneungwonju national university wonju gangwondo republic of korea. 3school of electrical engineering korea advanced institute of science and technology yuseonggu daejeon republic of korea. 4department of radiology seoul national university hospital jongnogu seoul republic of korea. 5department of electrical engineering stanford university stanford ca usa. 6brain science institute korea institute of science and technology seongbukgu seoul republic of korea. 7division of biomedical science and technology kist school korea national university of science and technology seongbukgu seoul republic of korea. 8khukist department of converging science and technology kyung hee university dongdaemungu seoul republic of korea. 9school of electrical engineering korea advanced institute of science and technology yuseonggu daejeon republic of korea. jjeong1kaist.ac.kr. 10bionics research center korea institute of science and technology seongbukgu seoul republic of korea. bcleekist.re.kr. 11division of biomedical science and technology kist school korea national university of science and technology seongbukgu seoul republic of korea. bcleekist.re.kr. 12khukist department of converging science and technology kyung hee university dongdaemungu seoul republic of korea. bcleekist.re.kr. contributed equally traditional wearable ultrasound devices pose challenges concerning the rigidity and environmental impact of leadbased piezoelectric materials. this study proposes a silicon nanocolumn capacitive micromachined ultrasonic transducer sncmut array for realtime wearable ultrasound imaging in disposable patches. using a leadfree design sncmut incorporates silicon nanocolumns to address existing issues and achieves high transmission efficiency 220 kpav flexibility and low power consumption. the specialized structure of sncmut enhances displacement efficiency enabling highresolution imaging while maintaining a thin flexible form factor 900 m. phantom imaging demonstrates its superior performance with high axial and lateral resolutions 0.52 and 0.55 mm and depth penetration 70 mm at low voltage 8.9 vpp. upon successful application to monitor both sides of the human carotid arteries sncmut offers clear ultrasound images and continuous blood pressure waveform monitoring. this proposed innovation presents significant potential for continuous medical imaging and cardiovascular health assessment addressing environmental concerns and reducing manufacturing costs 20. 2025. the authors. doi 10.1038s4146702561903x pmid 40676025 indexed for medline conflict of interest statement competing interests the authors declare no competing interests.",
    "32. nat commun. 2025 jul 171616577. doi 10.1038s41467025616567. chromatin interaction maps of human arterioles reveal mechanisms for the genetic regulation of blood pressure. liu y12 pandey r12 qiu q12 liu p12 xue h3 wang j4 therani b12 ying r4 usa k3 grzybowski m3 yang c3 mishra mk12 greene as5 cowley aw jr3 rao s678 geurts am3 widlansky me4 liang m910. author information 1department of physiology university of arizona college of medicinetucson tucson az usa. 2molecular systems medicine initiative university of arizona health sciences tucson az usa. 3department of physiology medical college of wisconsin milwaukee wi usa. 4cardiovascular center and department of medicine medical college of wisconsin milwaukee wi usa. 5the jackson laboratory bar harbor me usa. 6versiti blood research institute milwaukee wi usa. 7department of pediatrics division of hematology oncology and transplantation medical college of wisconsin milwaukee wi usa. 8department of cell biology neurobiology and anatomy medical college of wisconsin milwaukee wi usa. 9department of physiology university of arizona college of medicinetucson tucson az usa. mliang1arizona.edu. 10molecular systems medicine initiative university of arizona health sciences tucson az usa. mliang1arizona.edu. contributed equally arterioles are small blood vessels located just upstream of capillaries in nearly all tissues. despite the broad and essential role of arterioles in physiology and disease current knowledge of the functional genomics of arterioles is largely absent. here we report extensive maps of chromatin interactions singlecell expression and other molecular features in human arterioles and uncover mechanisms linking human genetic variants to gene expression in vascular cells and the development of hypertension. compared to large arteries arterioles exhibited a higher proportion of pericytes which were enriched for blood pressure bpassociated genes. bpassociated single nucleotide polymorphisms snps were enriched in chromatin interaction regions in arterioles. we linked bpassociated noncoding snp rs1882961 to gene expression through longrange chromatin contacts and revealed remarkable effects of a 4bp noncoding genomic segment on hypertension in vivo. we anticipate that our data and findings will advance the study of the numerous diseases involving arterioles. 2025. the authors. doi 10.1038s41467025616567 pmid 40675959 indexed for medline conflict of interest statement competing interests the authors declare no competing interests.",
    "33. adv cancer res. 20251663357. doi 10.1016bs.acr.2025.05.002. epub 2025 jun 6. cerebrospinal fluid considerations in glioma. pan s1 strahle jm2. author information 1department of neurosurgery washington university in st. louis school of medicine st. louis mo united states. 2department of neurosurgery washington university in st. louis school of medicine st. louis mo united states department of orthopedic surgery washington university in st. louis school of medicine st. louis mo united states department of pediatrics washington university in st. louis school of medicine st. louis mo united states. electronic address strahlejwustl.edu. cerebrospinal fluid csf circulates in the ventricular system and subarachnoid space and through its interaction with interstitial fluid facilitates nutrient and waste exchange to support the functional needs of cells in the brain and spinal cord. in the setting of primary brain tumors csf has been implicated in tumor pathogenesis by serving as both a reservoir and vehicle for factors which may support tumor progression therefore contributing to the tumor microenvironment. pathological manifestations of csf in the setting of brain tumors include hydrocephalus due to tumor obstruction of csf pathways csf seeding and leptomeningeal metastasis and transependymal flow. csf also has roles as a reservoir for biomarkers important in brain tumor detection and as a site for direct delivery of therapeutic agents to bypass the blood brain barrier. despite the intimate association between csf and brain tumors few studies have investigated mechanisms of local and global alterations of fluid flow in the setting of glioma the most common malignant primary brain tumor in the central nervous system. here we provide an overview of recent advances in our understanding of the roles implications regulations and diagnostictherapeutic implications of csf in glioma and how they may be leveraged for research and clinical application. copyright 2025. published by elsevier inc. doi 10.1016bs.acr.2025.05.002 pmid 40675688 indexed for medline",
    "34. sci rep. 2025 jul 1815126040. doi 10.1038s4159802510515y. comparison of conventional and radiomicsbased analysis of myocardial infarction using multimodal nonlinear optical microscopy. giardina g1 papp l1 krause a1 marchant j2 pallareslupon n2 kulkarni k2 spielvogel cp3 haberl d3 li x1 drexler w1 walton rd2 unterhuber a4 andreana m1. author information 1center for medical physics and biomedical engineering medical university of vienna vienna austria. 2ihu liryc univ. bordeaux inserm crctb u 1045 bordeaux france. 3division of nuclear medicine department of biomedical imaging and imageguided therapy medical university of vienna vienna austria. 4center for medical physics and biomedical engineering medical university of vienna vienna austria. angelika.unterhubermeduniwien.ac.at. myocardial infarction a leading cause of mortality worldwide leaves survivors at significant risk of recurrence caused by scarrelated reentrant ventricular tachyarrhythmias. effective treatment with ablation therapy requires a precise guidance system. nonlinear optical microscopy techniques such as second harmonic generation shg and twophoton excited fluorescence tpef are promising candidates for a highresolution alternative to conventional electrical mapping for assessing infarcted cardiac tissue. here we apply shg and tpef with a resolution advantage over commonly used electrical mapping techniques to assess exvivo sheep heart infarction. analyzing conventional and radiomic features allows for quantitative characterization of scar tissue. our machine learning classifier achieved high accuracy offering a promising datadriven approach for guiding insitu ablation therapy with increased precision. this study represents a significant step towards integrating quantitative image analysis in therapeutic interventions. 2025. the authors. doi 10.1038s4159802510515y pmid 40676090 indexed for medline conflict of interest statement declarations. competing interests the authors declare no competing interests. ethical statement the animal model was produced in accordance with the guidelines from directive 201063eu of the european parliament on the protection of animals used for scientific purposes. all animal experiments were approved by the french ministry of higher education and research for the care and use of experimental animals. the present study was reviewed and approved by the local ethical committee at the university of bordeaux ceea50. following the 3rs principles of reducing the number of animals used for research this study was conducted in parallel with other experiments on the same tissue to minimize animal use. our study follows the arrive 2.0 animals in research reporting in vivo experiments guidelines for reporting animal research.",
    "35. nat commun. 2025 jul 171616602. doi 10.1038s4146702561875y. inhibiting cd36 palmitoylation improves cardiac function postinfarction by regulating lipid metabolic homeostasis and autophagy. zhang q1234 li j23 liu x23 chen x123 zhu l123 zhang z123 hu y123 zhao t123 lou h123 xu h123 zhao w123 dong x123 sun z123 sun x123 yang b567 zhang y8910. author information 1state key laboratory of frigid zone cardiovascular diseases sklfzcd college of pharmacy and department of cardiology the second affiliated hospital harbin medical university harbin china. 2department of pharmacology sklfzcd state key laboratory province key laboratories of biomedicinepharmaceutics of china key laboratory of cardiovascular research ministry of education college of pharmacy harbin medical university harbin china. 3research unit of noninfectious chronic diseases in frigid zone 2019ru070 chinese academy of medical sciences harbin china. 4nhc key laboratory of molecular probe and targeted diagnosis and therapy molecular imaging research center mirc of harbin medical university harbin china. 5department of pharmacology sklfzcd state key laboratory province key laboratories of biomedicinepharmaceutics of china key laboratory of cardiovascular research ministry of education college of pharmacy harbin medical university harbin china. yangbfems.hrbmu.edu.cn. 6research unit of noninfectious chronic diseases in frigid zone 2019ru070 chinese academy of medical sciences harbin china. yangbfems.hrbmu.edu.cn. 7department of pharmacology and therapeutics melbourne school of biomedical sciences faculty of medicine dentistry and health sciences university of melbourne melbourne vic australia. yangbfems.hrbmu.edu.cn. 8state key laboratory of frigid zone cardiovascular diseases sklfzcd college of pharmacy and department of cardiology the second affiliated hospital harbin medical university harbin china. hmuzhangyonghotmail.com. 9department of pharmacology sklfzcd state key laboratory province key laboratories of biomedicinepharmaceutics of china key laboratory of cardiovascular research ministry of education college of pharmacy harbin medical university harbin china. hmuzhangyonghotmail.com. 10research unit of noninfectious chronic diseases in frigid zone 2019ru070 chinese academy of medical sciences harbin china. hmuzhangyonghotmail.com. contributed equally alterations in myocardial energy substrate metabolism and mitochondrial injury following myocardial infarction mi lead to structural and functional abnormalities of the heart. the fatty acid translocase cd36 cd36 plays a pivotal role in regulating lipid homeostasis and mitochondrial metabolism. here we demonstrate that inhibiting the palmitoylation of cd36 and the resulting alteration in its subcellular localization alleviates lipid metabolism disorders and mitochondrial dysfunction in cardiomyocytes of male mice postmi. mechanistically the inhibition of cd36 palmitoylation enhances cardiac function through a dual mechanism first by alleviating fatty acid overload mediated by plasma membrane cd36 thereby restoring lipid metabolic balance second by augmenting the activity of the mitochondrial cd36pgam5 signaling axis and modulating fundc1 and drp1 dephosphorylation which subsequently improves mitophagy efficiency. overall our study highlights the significant role of cd36 palmitoylation in preserving heart function by regulating downstream metabolic signaling pathways suggesting that targeting cd36 palmitoylation could be a promising therapeutic strategy for mi. 2025. the authors. doi 10.1038s4146702561875y pmid 40675975 indexed for medline conflict of interest statement competing interests the authors declare no competing interests.",
    "36. bmj open. 2025 jul 17157e096334. doi 10.1136bmjopen2024096334. longterm clinical impact of sex disparities in patients with st elevation acute myocardial infarction a systematic review and metaanalysis of adjusted observational studies. di pietro g1 improta r1 de filippo o2 birtolo li1 bruno e1 sardella g1 vizza cd1 dascenzo f2 stefanini g3 mancone m4. author information 1department of clinical internalanesthesiological and cardiovascular sciences universita degli studi di roma la sapienza rome italy. 2department of cardiology azienda ospedaliero universitaria citta della salute e della scienza di torino torino italy. 3department of biomedical sciences humanitas university milan italy. 4department of clinical internalanesthesiological and cardiovascular sciences universita degli studi di roma la sapienza rome italy massimo.manconeuniroma1.it. objectives we aimed to address an evidence gap by investigating the clinical impact of sex differences on longterm outcomes after primary percutaneous coronary intervention ppci for acute stelevation myocardial infarction. design systematic review and metaanalysis. data sources medline scopus and embase were searched through august 2024. eligibility criteria for selecting studies we included adjusted observational studies reporting hrs comparing longterm clinical outcomes beyond 1 year between women and men undergoing ppci for stelevation myocardial infarction. data extraction and synthesis two independent reviewers extracted data and assessed risk of bias using the robins i risk of bias in nonrandomised studies of interventions tool. data were pooled using generic inversevariance weighting computing risk estimates with 95 cis. heterogeneity was assessed cochran q statistic and quantified i2 statistic. results 22 observational studies globally encompassing 358 140 patients 169 659 women vs 188 490 men were included in the quantitative analysis. after a median followup of 3.3 years no significant differences in terms of allcause mortality were reported after multivariable adjustments adjusted hr adjhr 1.06 95 ci 0.99 to 1.14 p0.10. women had a higher rate of cardiac death compared with men after multivariable adjustments adjhr 1.86 95 ci 1.25 to 2.77 p0.002. no other significant differences in terms of recurrent mi stent thrombosis and target vessel revascularisation persisted between women and men after multivariable adjustments. conclusions women undergoing ppci for acute stelevation myocardial infarction experience an increased risk of cardiac death compared with men after a longterm followup. prospero registration number crd42024580932. authors or their employers 2025. reuse permitted under cc bync. no commercial reuse. see rights and permissions. published by bmj group. doi 10.1136bmjopen2024096334 pmid 40675647 indexed for medline conflict of interest statement competing interests none declared.",
    "37. acta physiol oxf. 2025 aug2418e70076. doi 10.1111apha.70076. activation of the carotid sinus nerve after acute myocardial infarction in a cardiorenal syndrome type 1 model in spraguedawley rats. de oliveira cavalheiro r1 brognara f2 da silva caa1 castania ja1 molina caf3 murphy d4 romano mmd5 salgado hc1. author information 1department of physiology ribeiro preto medical school university of so paulo ribeiro preto sp brazil. 2department of general and specialized nursing ribeiro preto medical school university of so paulo ribeiro preto sp brazil. 3urology ribeiro preto medical school university of so paulo ribeiro preto sp brazil. 4bristol medical school university of bristol bristol uk. 5cardiology department of internal medicine ribeiro preto medical school university of so paulo ribeiro preto sp brazil. aim to evaluate the effect of carotid sinus nerve stimulation csns in the progression of cardiorenal syndrome type 1 crs1 3 days after acute myocardial infarction ami. methods male rats were divided into four groups. csns was applied daily for 10 min over 3 days. cardiac renal and inflammatory parameters characterized the crs1 and the electroceutical effects of csns. results csns reduced the ischemic zone compared to the ami group not exposed to csns 32.7 2.2 vs. 8.0 1.8. heart rate bpm was increased in the ami group showing 440 7.6 at 48 h and 428 1.0 at 60 h postami. additionally arterial pressure mmhg was increased in the ami group at 48 h as follows mean 98 1.7 diastolic 89 2.1 and systolic 122 5.3. in contrast the csns ami group showed significant reductions of these parameters mean 79 2.0 diastolic 66 1.7 and systolic 99 2.7. renal injury was confirmed by increased apoptosis in the ami group. a significant increase in tnf was observed in both heart and kidneys pgmg of tissue in the ami group and reduced il6 and il1 levels in the csns ami group indicating an attenuation of the inflammatory responses by csns. conclusions this study demonstrates early cardiac and renal dysfunction in crs1 following ami associated with elevated inflammatory markers tnf il6 and il1 and renal apoptosis. therefore csns appears to be a promising electroceutical approach for crs1. besides on the basis of previous studies from our laboratory csns involves stimulation of the baroreflex activating the parasympathetic and inhibiting the sympathetic nervous system. 2025 scandinavian physiological society. published by john wiley sons ltd. doi 10.1111apha.70076 pmid 40673420 indexed for medline",
    "38. j transl med. 2025 jul 16231797. doi 10.1186s12967025061653. integrated analysis of blood microbiome and metabolites reveals key biomarkers and functional pathways in myocardial infarction. khan i1 panaiotov s2 attia ka3 mohammed aa3 uzair m4 khan i5 li z6 xie x7. author information 1department of genetics school of basic medical sciences lanzhou university lanzhou gansu 730000 china. 2microbiology department national center of infectious and parasitic diseases yanko sakazov 26 blvd. sofia 1504 bulgaria. 3department of biochemistry college of science king saud university riyadh 11451 saudi arabia. 4national institute for genomics and advanced biotechnology park road islamabad 45500 pakistan. 5department of microecology school of basic medical sciences dalian medical university dalian liaoning china. 6school of stomatology key laboratory of oral disease northwest minzu university lanzhou gansu china. lizhiqiang6767163.com. 7department of genetics school of basic medical sciences lanzhou university lanzhou gansu 730000 china. xdxielzu.edu.cn. background myocardial infarction mi has been linked to changes in the blood microbiome yet the interplay between microbiome and metabolome remains poorly understood. this study integrates blood microbiome profiling and metabolomic analysis to uncover biomarkers and pathways associated with mi. methods using 16 s rrna sequencing and lcms metabolomics blood samples from 24 mi patients and 24 healthy controls were analyzed. microbial diversity key taxa metabolites and their functional implications were evaluated. results while alpha and beta diversity of the microbiome showed no significant differences three bacterial taxa proteobacteria gammaproteobacteria and bacilli and twenty metabolites e.g. updlara4o urotensinrelated peptide and 9hydroxy octadecanoic acid were identified as potential biomarkers achieving an auc of 0.991. functional pathway analysis revealed upregulation in glycerolipid metabolism and mtor signaling pathways which were significantly correlated with clinical markers of mi. conclusion this integrative approach highlights the diagnostic potential of blood microbiomemetabolome dynamics in mi and suggests mechanistic pathways that could guide future interventions. 2025. the authors. doi 10.1186s12967025061653 pmcid pmc12269162 pmid 40671045 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this study was approved by the ethical committee of the lanzhou university. all participants provided informed written consent at enrollment. consent for publication not applicable. competing interests the authors declare that they have no competing interests.",
    "39. bmc emerg med. 2025 jul 16251129. doi 10.1186s12873025012897. the diagnostic accuracy of the esc 01hour algorithm in nonstsegment elevation myocardial infarction in a crowded emergency department a realworld experience from a singlecenter in trkiye. kudu e12 kucukardali ae34 altun m5 ztrk 6 altunba e3 karacabey s3 sanri e3 denizbasi a3. author information 1department of emergency medicine marmara university school of medicine istanbul trkiye. dr.emre.kudugmail.com. 2department of emergency medicine marmara university pendik training and research hospital istanbul trkiye. dr.emre.kudugmail.com. 3department of emergency medicine marmara university school of medicine istanbul trkiye. 4department of emergency medicine sultanbeyli state hospital istanbul trkiye. 5department of emergency medicine marmara university pendik training and research hospital istanbul trkiye. 6department of cardiology marmara university pendik training and research hospital istanbul trkiye. background the rapid and accurate diagnosis of nonstsegment elevation myocardial infarction nstemi is critical to improving patient outcomes and reducing emergency department ed overcrowding. the european society of cardiology esc 01hour algorithm utilizing highsensitivity cardiac troponin t hsctnt levels has demonstrated high diagnostic performance internationally. this study aimed to evaluate its diagnostic accuracy in a highvolume ed setting in trkiye. methods this singlecenter retrospective cohort study was conducted at marmara university pendik training and research hospital trkiye from september 1 to december 31 2022. adults presenting with acute chest discomfort and undergoing hsctnt testing per the esc 01hour algorithm were included. patients with stsegment elevation missing data pregnancy or those discharged against medical advice were excluded. the primary outcome was nstemi diagnosis the secondary outcome was major adverse cardiac events mace within 30 days. results of 3529 eligible patients 3216 were included. the mean age of the patients was 53.9 16.4 years and 58.3 were male. nstemi was diagnosed in 319 patients 9.9. according to the esc algorithm 54.4 of patients were classified as ruleout 31.3 as observe and 12.3 as rulein. the sensitivity and negative predictive value npv for nstemi in the ruleout group were both 100. in the rulein group the specificity was 91.16 and the positive predictive value ppv was 59.14. mace occurred in 13.6 436 patients within 30 days 0.7 in the ruleout group 13.9 in the observe group and 67.0 in the rulein group. conclusions the esc 01hour algorithm is highly effective for ruling out nstemi in trkiye demonstrating excellent sensitivity and npv. while it facilitates early discharge of lowrisk patients enhancements are needed for risk stratification in intermediaterisk groups. its implementation could optimize ed resource utilization and improve clinical outcomes. clinical trial number not applicable. 2025. the authors. doi 10.1186s12873025012897 pmcid pmc12269136 pmid 40670967 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate marmara university clinical research ethics committee approved the study protocol protocol number 09.2023.960 and the study was conducted in accordance with the declaration of helsinki. since the study was conducted retrospectively informed consent was not obtained from the patients. for patients contacted via phone verbal informed consent was first obtained and subsequently outcome data were collected either through direct communication with the patient or by accessing their electronic health records. consent for publication not applicable. competing interests the authors declare that they have no competing interests.",
    "40. bmc cardiovasc disord. 2025 jul 16251511. doi 10.1186s1287202504960w. enhancing selfcare in postmi patients a familysupported educational intervention based on the theory of planned behavior. arman a1 attar a2 izadpanah p3 bahja h1 jeihooni ak4. author information 1student research committee shiraz university of medical sciences shiraz iran. 2department of cardiovascular medicine taha clinical trial group shiraz university of medical sciences shiraz iran. 3department of cardiology school of medicine namazi teaching hospital shiraz university of medical sciences shiraz iran. 4nutrition research center department of public health school of health shiraz university of medical sciences shiraz shiraz iran. khani1512yahoo.com. introduction myocardial infarction mi ranks among the major causes of death and disability globally. the modifiable risk factors are very important not only for its prevention but also for its longterm management. adherence to selfcare plays a very important part in improving outcomes following mi. however after mi patient adherence declines over time. the theory of planned behavior tpb is a sociopsychological theory that can be a model to develop focused interventions which will improve selfcare practices. methods this quasiexperimental study was conducted on 140 postmi patients in fasa city iran 20232024. they were randomly allocated to the intervention 70 or control 70 group. participants in the intervention group received a 10session education program based on the tpb content related to selfcare components. the control group only received standard care. validated scales assessed selfcare behavior tpb constructs attitude subjective norms perceived behavioral control lifestyle modification and behavioral intention at baseline and 4month followup. results there was no significant difference between both groups in terms of demographic and baseline variables and tpb domains p 0.05. however at four months following the intervention the intervention group showed a significant improvement in all evaluated variables compared to the control group p 0.001. conclusion the tpbbased educational intervention can meaningfully improve the selfcare behavior of mi patients. future work should assess the sustainability over time of these changes and the feasibility of using digital health technology to support enhanced patient compliance. 2025. the authors. doi 10.1186s1287202504960w pmid 40670952 indexed for medline conflict of interest statement declarations. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "41. bmc cardiovasc disord. 2025 jul 16251516. doi 10.1186s1287202504989x. hatch score associated with newonset atrial fibrillation in patients with stsegment elevation myocardial infarction. qin s1 tao y1 tang c1 zhang q2 li y3 fei z4. author information 1department of cardiology the first peoples hospital of yuhang district hangzhou zhejiang 311100 china. 2department of cardiology suining county peoples hospital xuzhou jiangsu 221200 china. 13852440906163.com. 3department of cardiology the first peoples hospital of yuhang district hangzhou zhejiang 311100 china. hzyl2000163.com. 4department of ultrasound the fourth affiliated hospital of nanjing medical university nanjing jiangsu 210029 china. zhengdongfei1982163.com. background the hatch score a new atrial fibrillation af risk model has drawn wide attention. however in patients with stsegment elevation myocardial infarction stemi the relationship between the hatch score and noaf remains unclear. this study aimed to assess the association between hatch score and newonset af noaf after percutaneous coronary intervention pci in stemi patients. methods this singlecenter retrospective observation consecutively selected patients diagnosed with stemi who underwent primary pci. all patients received continuous electrocardiogram monitoring during hospitalization 36 h. hatch score was calculated based on hypertension 1 point age 75 years 1 point stroke or tia 2 point copd 1 point and hf 2 point. results a total of 774 patients were included in this study of whom 65.37 were male with a mean age of 63.53 13.11 years 73 patients 9.43 developed noaf. roc curve demonstrated that the auc of the hatch score was 0.731 the cut off value was 2.5. multivariate logistic regression analysis indicated that the hatch score or 1.66 95 ci 1.411.95 p 0.001 or hatch score 3 or 4.10 95 ci 2.397.02 p 0.001 was an independent risk predictor for noaf. the rcs analysis revealed a linear correlation between the hatch score and noaf p for overall 0.001. conclusions elevated hatch score is an independent risk factor for the development of noaf after pci in stemi patients. there was a linear doseresponse relationship between hatch score and noaf. 2025. the authors. doi 10.1186s1287202504989x pmid 40670941 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this study adhered to the relevant regulations of the declaration of helsinki. this study protocol was reviewed and approved by the ethics committee of suining county peoples hospital no. ll2023042. as this was a retrospective study with no risk to patients the requirement for written informed consent was waived. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "42. bmc geriatr. 2025 jul 16251535. doi 10.1186s12877025061690. ntprobnp changes predict outcomes in elderly type 2 myocardial infarction patients. ma j1 li a2 bian s2. author information 1department of geriatric cardiology the second medical center national clinical research center for geriatric diseases chinese pla general hospital no. 28 fuxing road haidian district beijing 100853 china. majinling1163.com. 2department of geriatric cardiology the second medical center national clinical research center for geriatric diseases chinese pla general hospital no. 28 fuxing road haidian district beijing 100853 china. background nterminal probtype natriuretic peptide ntprobnp is useful to predict adverse outcomes. change in ntprobnp level may provide additional actionable risk assessment information. this study aimed to determine the association of change in ntprobnp level with adverse outcomes among elderly individuals with type 2 myocardial infarction mi. methods a retrospective analysis was conducted among elderly individuals with type 2 mi between december 2010 and december 2022. change of ntprobnp level was determined as the difference between the baseline and last measurement obtained during the period of 30 days. results a total of 3007 participants aged 80 years and older were included. the patients were divided in accordance with the change in ntprobnp level into those with ntprobnp change 30 decrease ntprobnp change 30 decrease and 10 increase and ntprobnp change 10 increase. the patients with ntprobnp change 10 increase were older had higher systolic blood pressure loop diuretics use and higher incidence of atrial fibrillation and chronic kidney disease. the quartile of change in ntprobnp 10 increase was markedly associated with increased risk of incident hf as well as allcause and cardiovascular mortality. the incidence rate of mortality increased in a graded fashion with change in ntprobnp level. the kaplanmeier eventfree curves showed that patients with ntprobnp change 10 increase had the highest risk followed by those with ntprobnp change 30 decrease and 10 increase and ntprobnp change 30 decrease. conclusions the change in ntprobnp level can be used for identifying patients at a high risk of incident hf as well as cardiovascular and allcause mortality in elderly individuals with type 2 mi. it may be a promising biomarker to guide personalized therapy optimization. 2025. the authors. doi 10.1186s12877025061690 pmcid pmc12269173 pmid 40670929 indexed for medline conflict of interest statement declarations. ethics approval and consent to participate this study was approved by the chinese pla general hospital ethics review board. the requirement for informed consent was waived for this study owing to its retrospective design by the chinese pla general hospital ethics review board. consent for publication not applicable. competing interests the authors declare no competing interests.",
    "43. jacc cardiovasc interv. 2025 jul 14181316311642. doi 10.1016j.jcin.2025.05.032. outcomes of lesions with discordance between ffr and nonhyperemic pressure ratios. ha et1 nishi t1 takahashi t2 yamazaki t3 saito y3 kuramitsu s4 kawase y5 parikh ma6 waksman r7 kobayashi y8. author information 1newyorkpresbyterian brooklyn methodist hospital brooklyn new york usa. 2smidt heart institute cedarssinai medical center california usa. 3department of cardiovascular medicine chiba university graduate school of medicine chiba japan. 4sapporo cardiovascular clinic sapporo heart center sapporo japan. 5gifu heart center gifu japan. 6newyorkpresbyterian brooklyn methodist hospital brooklyn new york usa weill cornell medical college new york new york usa. 7medstar washington hospital center washington dc usa. 8newyorkpresbyterian brooklyn methodist hospital brooklyn new york usa weill cornell medical college new york new york usa. electronic address dxl9003med.cornell.edu. background discordance between fractional flow reserve ffr and nonhyperemic pressure ratios nhprs can occur in about 20 of clinical cases creating treatment dilemmas in the cardiac catheterization laboratory. objectives the authors sought to perform a systematic review and metaanalyses investigating the longterm outcome of deferral strategy in patients found to have discordant physiology. methods the primary comparison tested the longterm prognosis of patients who were deferred for discordant physiology vs those deferred for concordant negative results. various nhprs were compared with ffr. the primary endpoint was a composite of death allcause or cardiac and myocardial infarctionrevascularization with several definitions. secondary endpoint consisted of death or myocardial infarction. the study is registered with prospero crd42024628393. results six eligible trials with 9854 intermediate lesions deferred for pci were considered in the analysis. compared with concordantnegative physiology ffrnhprs deferral of pci for discordant physiology was associated with an increase in the primary endpoints ffrnhprs hr 2.73 1.953.80 p 0.00001 and ffrnhprs hr 3.292.334.64 p 0.00001. secondary dichotomous analysis showed that deferral of pci in both discordant groups was associated with an increase in the hard endpoints death or myocardial infarction compared with concordantnegative physiology. exploratory analysis comparing revascularization vs deferral groups within discordant physiology demonstrated reduction in the primary endpoint in the ffrnhprs group but not in the ffrnhprs group. conclusions deferral of pci in discordantphysiology was associated with worse longterm outcomes compared with the concordantnegative physiology. there may be a benefit of revascularization in ffrnhprs lesions which requires further investigation. copyright 2025 american college of cardiology foundation. published by elsevier inc. all rights reserved. doi 10.1016j.jcin.2025.05.032 pmid 40669964 indexed for medline conflict of interest statement funding support and author disclosures dr parikh serves on the advisory boards of abbott vascular boston scientific and medtronic. dr waksman is a consultant for abbott vascular biotronik boston scientific cordis medtronic philips igt picardia ltd. transmural systems inc. receives institutional grant support from biotronik boston scientific medtronic and philips igt and is an investor in transmural systems inc. dr kobayashi has received institutional research support from cathworks. all other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",
    "44. j investig med high impact case rep. 2025 jandec1323247096251352370. doi 10.117723247096251352370. epub 2025 jul 16. rare case of acute pancreatitis presenting with stsegment elevation. leker k1 johal p2. author information 1eisenhower medical center rancho mirage ca usa. 2trinity health livonia mi usa. when first presented stsegment elevation on ekg electrocardiogram requires close scrutiny. the most concerning of possible diagnoses is acute coronary syndrome yet it is not the only clinical entity that can cause stsegment elevation. herein we present a case of a 62yearold male current smoker with past medical history of uncontrolled diabetes hypertension and hyperlipidemia presenting with abdominal pain for 1 week duration. his initial admission ekg illustrated stsegment elevation however his clinical presentation lack of anginal symptoms normal bedside transthoracic echocardiogram and normal range troponin were not indicative of myocardial infarction. in fact he was found to have elevated lipase and ct findings consistent with acute pancreatitis. this case highlights an uncommon presentation of pancreatitis and illustrates the importance of obtaining a comprehensive clinical history when evaluating patients to ensure patients receive efficient and appropriate care. doi 10.117723247096251352370 pmcid pmc12268134 pmid 40667677 indexed for medline conflict of interest statement declaration of conflicting intereststhe authors declared no potential conflicts of interest with respect to the research authorship andor publication of this article.",
    "45. j mol histol. 2025 jul 15564230. doi 10.1007s10735025105170. pannexin1 via p2rx7amphiregulin contributes to cardiac fibrosis post myocardial infarction. deng n12 you l2 guo h1 wei y1 xu f2 chen d2 luo s2 huang s2 zuo s2 li w1 si x3. author information 1department of cardiology affiliated hospital of guizhou medical university no. 28 guiyi road guiyang 550004 guizhou province china. 2guizhou medical university no. 9 beijing road guiyang 550004 guizhou province china. 3department of cardiology affiliated hospital of guizhou medical university no. 28 guiyi road guiyang 550004 guizhou province china. sixiaoyungmc.edu.cn. the primary pathological mechanism underlying ventricular remodeling and cardiac dysfunction following myocardial infarction mi is predominantly mediated by cardiomyocyte apoptosis. pannexin1 panx1 channels which open during apoptosis facilitate the release of atp from dying cells. however the functional significance of panx1 in mediating cardiomyocyte apoptosis and its contribution to myocardial infarction progression remain to be fully elucidated. to investigate the regulatory role of panx1 in cardiomyocyte apoptosis following mi and elucidate its underlying molecular mechanisms. we conducted both in vivo and vitro studies. in vivo we observed a significant elevation of panx1 expression levels in postmi mice which facilitated macrophage recruitment and subsequently triggered upregulation of amphiregulinareg. in vitro hl1 cells exposure to hypoxiareoxygenation hr induced apoptosis accompanying with the upregulation of panx1 enhanced extracellular atp release. and these alterations promoted the recruitment of raw264.7 cells subsequently elevating areg levels. these effects were mitigated by the knockdown of panx1. to confirm panx1s role in mi hearts aav9panx1rnai and negative control vectors were administered into the hearts of mice. over 28 days postmi panx1 knockdown significantly enhanced cardiac function and attenuated myocardial fibrosis. our findings reveal that panx1 plays a crucial role in facilitating a link between apoptotic cardiomyocyte and macrophage contributing to modulate myocardial fibrosis and cardiac dysfunctional recovery postmi via the areg. furthermore the panx1p2rx7areg pathway is essential for facilitating a link between apoptotic cardiomyocytes and macrophages in mice following mi. 2025. the authors under exclusive licence to springer nature b.v. doi 10.1007s10735025105170 pmid 40665155 indexed for medline conflict of interest statement declarations. conflict of interest the authors declare no competing interests."
  ]
}